Chronic lymphocytic leukaemia refractory

Treatment related acute myeloid leukaemia

Anemia, Refractory, With Excess of Blasts

Epstein-Barr virus associated Diffuse Large B-Cell Lymphoma

High grade B-cell lymphoma with MYC and BCL2 and/or BCL6 rearrangements

Core binding factor acute myeloid leukemia

Diffuse large B-cell lymphoma refractory

Recurrent High-Grade B-Cell Lymphoma with MYC and BCL2 or BCL6 Rearrangements

Recurrent T-Cell/Histiocyte-Rich Large B-Cell Lymphoma

Refractory T-Cell/Histiocyte-Rich Large B-Cell Lymphoma

Refractory T Acute Lymphoblastic Leukemia

IDH2 mutation Acute Myeloblastic Leukemia

Acute Myeloid Leukemia with FLT3/ITD Mutation

Acute Myeloid Leukemia with Myelodysplasia-Related Changes

Acute myeloid leukemia with mutated NPM1

Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

Aggressive-Phase Chronic Myelocytic Leukemia

Philadelphia Chromosome Positive Acute Myeloid Leukemia

Blastic Plasmacytoid Dendritic Cell Neoplasm

Recurrent Transformed Chronic Lymphocytic Leukemia

Refractory Transformed Chronic Lymphocytic Leukemia

Blast Phase Chronic Granulocytic Leukemia

Philadelphia chromosome positive chronic myelogenous leukemia

Precursor B-lymphoblastic lymphoma/leukemia recurrent

Precursor B-lymphoblastic lymphoma/leukemia refractory

ALK-positive anaplastic large cell lymphoma

Refractory Diffuse Large B-Cell Lymphoma Activated B-Cell Type

Refractory Adult Acute Lymphoblastic Leukemia

Refractory Mixed Phenotype Acute Leukemia

Refractory High Risk Myelodysplastic Syndrome

Recurrent B Acute Lymphoblastic Leukemia

Refractory B Acute Lymphoblastic Leukemia

BCR-ABL Negative Atypical Chronic Myeloid Leukemia

Recurrent Childhood Acute Lymphoblastic Leukemia

refractory acute lymphoid leukemia in relapse

T-cell acute lymphoblastic leukemia in relapse

Philadelphia positive acute lymphocytic leukaemia

Recurrent Mixed Phenotype Acute Leukemia

Refractory Acute Leukemia of Ambiguous Lineage

CD19-positive B-cell acute lymphoblastic leukemia

Precursor B-Cell Lymphoblastic Leukemia-Lymphoma

Refractory Indolent Adult Non-Hodgkin Lymphoma

Refractory Indolent Non-Hodgkin Lymphoma

T-cell/histiocyte rich large B-cell lymphoma

Philadelphia Chromosome Negative Acute Lymphoblastic Leukemia

Hormone receptor positive HER2 negative breast cancer

Metastatic castration-resistant prostate cancer

Peripheral T-cell lymphoma unspecified recurrent

Refractory Transformed Indolent B-Cell Non-Hodgkin Lymphoma


Philadelphia chromosome-positive chronic myeloid  leukemia in chronic phase

Acute Myeloid Leukemia with Myelodysplasia-Related Changes

Diffuse large B-cell lymphoma refractory

CCUS Clonal Cytopenia of Undetermined Significance

Anemia, Refractory, With Excess of Blasts

BCR-ABL Negative Atypical Chronic Myeloid Leukemia

United States
European Union
Canada
Australia
Iceland
Liechtenstein
Norway


Complement c5 inhibitory humanized recycling monoclonal antibody (rg-6107 )

Crovalimab (genetical recombination) (JAN)

Immunoglobulin g1, anti-(human complement c5)(humanized ro7112689 heavy chain), disulfide with humanized ro7112689 light chain, dimer

United States
China
European Union
Japan
Canada
Iceland
South Korea
Liechtenstein
Norway


Serelaxin (genetical recombination) (JAN)


Anisoylated plasminogen streptokinase activator complex


Hepatitis C virus serine protease, NS3/NS4A


Anti-LAG-3 monoclonal antibody (Bristol-Myers Squibb)

Anti-lymphocyte activation gene 3 monoclonal antibody

Recurrent Lung Non-Squamous Non-Small Cell Carcinoma

Squamous cell carcinoma of head and neck metastatic

Locally Advanced Head and Neck Squamous Cell Carcinoma

Squamous Cell Carcinoma of Head and Neck

Microsatellite Stable Colorectal Carcinoma

Microsatellite Instability-high Solid Tumors

Malignant neoplasm of gastro-oesophageal junction

Metastatic Non-Squamous Non-Small Cell Lung Carcinoma


Denosumab Biosimilar (Amneal Intermediate, Inc.)

Tumor necrosis factor ligand superfamily member 11

United States
European Union
Iceland
South Korea
Liechtenstein
Norway


Ustekinumab Biosimilar (Bio-Thera Solutions, Ltd.)

United States
European Union
United Kingdom
Iceland
Liechtenstein
Norway


European Union
United Kingdom
Iceland
Liechtenstein
Norway


China
United Kingdom
Bulgaria
Germany
Denmark
Spain
Finland
Greece
Hungary
Italy
Poland
Portugal
Sweden


Accelerated phase Philadelphia chromosome positive chronic myeloid leukemia

Philadelphia chromosome positive chronic myeloid leukemia in blast crisis

Philadelphia chromosome-positive chronic myeloid  leukemia in chronic phase

Philadelphia chromosome positive chronic myelogenous leukemia

Aggressive-Phase Chronic Myelocytic Leukemia

Blast Phase Chronic Granulocytic Leukemia

Hormone receptor positive HER2 negative breast cancer

Human epidermal growth factor 2 negative carcinoma of breast

Philadelphia Chromosome Positive Leukemia

United States
European Union
Japan
Australia
Iceland
Liechtenstein
Norway


Trastuzumab emtansine biosimilar (Zydus Cadila)

ADO-Trastuzumab Emtansine Biosimilar (Zydus Cadila Healthcare Ltd.)

Trastuzumab emtansine (genetical recombination) (JAN)

恩美曲妥珠单抗生物类似药（Zydus Cadila Healthcare Ltd.）

Antibody drug conjugate (ADC)
Biosimilar


Anti-calcitonin gene-related peptide monoclonal antibody

United States
European Union
Japan
United Kingdom
Canada
Australia
Iceland
South Korea
Liechtenstein
Norway


ビクテグラビルナトリウム/エムトリシタビン/テノホビル アラフェナミドフマル酸塩

Bictegravir Sodium/Emtricitabine/Tenofovir Alafenamide Fumarate

United States
China
European Union
Japan
Canada
Australia
Iceland
South Korea
Liechtenstein
Norway


INTERFERON ALFA-2B(Merck Sharp & Dohme )

Interferon alfa-2b (Merck Sharp & Dohme)


CCUS Clonal Cytopenia of Undetermined Significance


Human Fibrinogen(Chengdu Rongsheng Pharmaceutical)


Recombinant human thrombin (Zelgen Biopharma)


Fluticasone Furoate/Umeclidinium Bromide/Vilanterol Trifenatate

フルチカゾンフランカルボン酸エステル/ウメクリジニウム臭化物/ビランテロールトリフェニル酢酸塩

fluticasone furoate+ vilanterol + umeclidinium bromide

Moderate chronic obstructive pulmonary disease

United States
China
European Union
Japan
Canada
Iceland
Liechtenstein
Norway
Singapore


United States
European Union
Iceland
Liechtenstein
Norway


Advanced Triple-Negative Breast Carcinoma

Estrogen receptor positive breast cancer

Estrogen receptor-negative breast cancer

Blast Phase Chronic Granulocytic Leukemia

Acute myeloid leukaemia with 11q23 abnormality

Acute myeloid leukemia with multilineage dysplasia

Adult Acute Monoblastic and Monocytic Leukemia

Adult acute myeloid leukemia with del(5q)

Aggressive-Phase Chronic Myelocytic Leukemia

Anemia, Refractory, With Excess of Blasts

Human Papillomavirus-Related Head and Neck Neoplasms

Recurrent Platinum-Resistant Ovarian Carcinoma

recurrent primary peritoneal cavity cancer

refractory acute lymphoid leukemia in relapse

Refractory cytopenia with multilineage dysplasia and ringed sideroblasts

China
European Union
Canada
Iceland
Liechtenstein
Norway


Acetaminophen/Anhydrous Caffeine/Chlorpheniramine Maleate/Pseudoephedrine Hydrochloride/DL-Methylephedrine Hydrochloride/Thiamine Nitrate/Ascorbic Acid

对乙酰氨基酚/咖啡因/马来酸氯苯那敏/盐酸伪麻黄碱/盐酸甲基麻黄碱/硝酸硫胺/维生素C


Chronic rhinosinusitis with nasal polyps

United States
European Union
Canada
Australia
Iceland
South Korea
Liechtenstein
Norway


Platelet-derived growth factor receptor beta

Vascular endothelial growth factor receptor 1

Vascular endothelial growth factor receptor 2

Vascular endothelial growth factor receptor 3

Acute Myeloid Leukemia with FLT3/ITD Mutation

Advanced Lung Non-Small Cell Squamous Carcinoma

Advanced Lung Non-Squamous Non-Small Cell Carcinoma

Advanced Pancreatic Ductal Adenocarcinoma

Anemia, Refractory, With Excess of Blasts

Barretts esophagus with high grade dysplasia

Chronic lymphocytic leukaemia refractory

Idiopathic pulmonary arterial hypertension

Locally Advanced Clear Cell Renal Cell Carcinoma

Locally Advanced Hepatocellular Carcinoma

Locally Advanced Malignant Solid Neoplasm

Locally Advanced Pancreatic Adenocarcinoma

Metastatic castration-resistant prostate cancer

Metastatic Clear Cell Renal Cell Carcinoma

Metastatic HER2-Negative Breast Carcinoma

Metastatic Malignant Neoplasm to the Leptomeninges

Metastatic Non-Squamous Non-Small Cell Lung Carcinoma

Metastatic Thyroid Gland Medullary Carcinoma

Platinum-Resistant Primary Peritoneal Carcinoma

Recurrent Childhood Acute Lymphoblastic Leukemia

Refractory cytopenia with multilineage dysplasia

Squamous cell carcinoma of head and neck metastatic

Urothelial Carcinoma of the Urinary Bladder

United States
China
European Union
Japan
Australia
Iceland
Liechtenstein
Norway


Pertuzumab biosimilar (Chia-tai Tianqing)

Pertuzumab Biosimilar (Chia Tai Tianqing Pharmaceutical Group Co., Ltd.)


Non ST segment elevation acute coronary syndrome


Octanedioic acid hydroxyamide phenylamide

Acute myeloid leukaemia with 11q23 abnormality

ALK-positive anaplastic large cell lymphoma

Anemia, Refractory, With Excess of Blasts

CD30-Positive recurrent or refractory Cutaneous T-Cell Lymphoma

Estrogen receptor positive breast cancer

Locally Advanced Pancreatic Adenocarcinoma

Metastatic castration-resistant prostate cancer

Platinum-Sensitive Primary Peritoneal Carcinoma

Subcutaneous Panniculitis-Like T-Cell Lymphoma


Sleep Initiation and Maintenance Disorders

United States
European Union
United Kingdom
Canada
Australia
Iceland
Liechtenstein
Norway


Teriparatide Biosimilar (Teva Pharmaceuticals)

Recombinant polypeptide
Biosimilar
Peptide Hormone


Philadelphia chromosome-positive chronic myeloid leukemia in chronic phase with the T315I mutation

Philadelphia chromosome positive chronic myelogenous leukemia

Philadelphia positive acute lymphocytic leukaemia

Blast Phase Chronic Granulocytic Leukemia

Aggressive-Phase Chronic Myelocytic Leukemia

Recurrent Ph-Like Acute Lymphoblastic Leukemia

Metastatic human epidermal growth factor 2 positive carcinoma of breast

Philadelphia Chromosome Positive Leukemia

BCR-ABL1 positive Acute Lymphoblastic Leukemia

Precursor B-Cell Lymphoblastic Leukemia-Lymphoma

United States
China
European Union
Japan
United Kingdom
Canada
Australia
Iceland
South Korea
Liechtenstein
Norway


Retinal vein occlusion-related macular edema

United States
European Union
Canada
Iceland
Liechtenstein
Norway


Paromomycin topical (Appili Therapeutics)


Trastuzumab Biosimilar (Aurobindo Pharma Ltd.)

HER2 positive Gastroesophageal Junction Adenocarcinoma


Childhood Central Nervous System Neoplasm

United States
China
European Union
Japan
Australia
Iceland
South Korea
Liechtenstein
Norway


Human immunodeficiency virus type 1 protease


Advanced Gastroesophageal Junction Adenocarcinoma

EGFR positive non-small cell lung cancer

EGFR T790M Mutation Positive Non-Small Cell Lung Carcinoma

Locally Advanced Pancreatic Adenocarcinoma


Acetaminophen/Guaifenesin/Anhydrous Caffeine/DL-Methylephedrine Hydrochloride/Chlorpheniramine Maleate


Associated Pulmonary Arterial Hypertension

United States
China
European Union
Australia
India
Iceland
Liechtenstein
Norway


Teriparatide Biosimilar (Beijing Genetech Pharmaceutical Co. Ltd.)

特立帕肽生物类似药（Beijing Genetech Pharmaceutical Co. Ltd.）


Ozoralizumab (genetical recombination) (JAN)


United States
China
Japan
Canada
South Korea
Saudi Arabia


Daratumumab Injection (Subcutaneous Injection)

Daratumumab(Genetical Recombination)/Vorhyaluronidase Alfa(Genetical Recombination)

Daratumumab（Genetical Recombination）/Vorhyaluronidase Alfa（Genetical Recombination）

Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

Monoclonal Gammopathy of Undetermined Significance


Anti-CTLA-4 antibody (Innovent Biologics)

Ipilimumab Biosimilar (Innovent Biologics (Suzhou) Co. Ltd.)

Ipilimumab biosimilar (Innovent Biologics)

重组全人源抗细胞毒T淋巴细胞相关抗原4 (CTLA-4)单克隆抗体 (信达生物)

Cytotoxic T-Lymphocyte-Associated Antigen 4

Mismatch repair-deficient Colonic Cancer

Advanced Gastroesophageal Junction Adenocarcinoma

Epstein-Barr virus associated gastric carcinoma

Microsatellite instability-high colorectal cancer


地舒单抗生物类似药(Chemical Works of Gedeon Richter)

Denosumab Biosimilar(Chemical Works of Gedeon Richter)

Denosumab Biosimilar (Chemical Works of Gedeon Richter Plc)

地舒单抗生物类似药（Chemical Works of Gedeon Richter Plc）

Tumor necrosis factor ligand superfamily member 11

United States
European Union
Iceland
South Korea
Liechtenstein
Norway


PD-L1 positive Esophageal Squamous Cell Carcinoma

Locally Advanced Gastroesophageal Junction Adenocarcinoma

Metastatic Gastroesophageal Junction Adenocarcinoma

Resectable Lung Non-Small Cell Carcinoma

HER2 negative Gastroesophageal Junction Adenocarcinoma

Locally Advanced Esophageal Squamous Cell Carcinoma

Locally Advanced Lung Non-Squamous Non-Small Cell Carcinoma

Metastatic Non-Squamous Non-Small Cell Lung Carcinoma

Oesophageal squamous cell carcinoma recurrent

Locally Advanced Lung Non-Small Cell Carcinoma

Unresectable Esophageal Squamous Cell Carcinoma

Metastatic Esophageal Squamous Cell Carcinoma

Microsatellite Instability-high Solid Tumors

HER2-expressing Gastroesophageal Junction Adenocarcinoma

Microsatellite instability-high colorectal cancer

HER2 Positive Gastroesophageal Adenocarcinoma

Urothelial Carcinoma of the Urinary Bladder

HER2 Positive Muscle Invasive Bladder Carcinoma

Squamous cell carcinoma of head and neck metastatic

Unresectable Lung Non-Small Cell Carcinoma

Squamous cell carcinoma of the oral cavity

Metastatic Castration-Sensitive Prostate Carcinoma

Metastatic castration-resistant prostate cancer

Hormone receptor positive HER2 negative breast cancer

Squamous Cell Carcinoma of Head and Neck

Metastatic Microsatellite Stable Colorectal Carcinoma

Diffuse large B-cell lymphoma refractory

HER2 positive Gastroesophageal Junction Adenocarcinoma

Locally Advanced Hepatocellular Carcinoma

Locally Advanced Malignant Solid Neoplasm

Advanced Lung Non-Small Cell Squamous Carcinoma

Advanced Triple-Negative Breast Carcinoma

CD30-Positive recurrent or refractory Cutaneous T-Cell Lymphoma

Metastatic Carcinoma to the Uterine Cervix

PD-L1 positive Transitional Cell Carcinoma

Secondary Central Nervous System Lymphoma

United States
China
European Union
Japan
Canada
Australia
India
Israel
Iceland
Liechtenstein
Norway


Protein kinase AMP-activated non-catalytic subunit beta 1


Pegfilgrastim  Biosimilar (Lunan Pharmaceutical Group Co., Ltd.)

Pegylated Human Granulocyte Colony-stimulating Factor (Lunan Pharma)

培非格司亭生物类似药（Lunan Pharmaceutical Group Co., Ltd.）


BCR-ABL Negative Atypical Chronic Myeloid Leukemia

Philadelphia chromosome positive chronic myelogenous leukemia


Denileukin Diftitox (Genetical Recombination)

Denileukin difitox (genetical recombination) (JAN)

Interleukin-2/diptheria toxin fusion protein


Trastuzumab biosimilar(Shanghai Henlius Biotech, Inc.)

Trastuzumab Biosimilar (Shanghai Henlius Biotech, Inc.)

曲妥珠单抗生物类似药（Shanghai Henlius Biotech, Inc.）

HER2 positive Gastrooesophageal junction cancer

HER2 positive Gastroesophageal Junction Adenocarcinoma

Metastatic human epidermal growth factor 2 positive carcinoma of breast

United States
China
European Union
Canada
Australia
Iceland
Liechtenstein
Norway
Philippines
Thailand


Bevacizumab Biosimilar (Outlook Therapeutics, Inc.)

European Union
United Kingdom
Iceland
Liechtenstein
Norway


Metabolic Dysfunction Associated Steatohepatitis


Sleep Initiation and Maintenance Disorders


Bevacizumab biosimilar(Dr. Reddy's Laboratories)

Advanced Lung Non-Squamous Non-Small Cell Carcinoma


Small molecule drug
Therapeutic radiopharmaceuticals

European Union
Iceland
Liechtenstein
Norway


Anti-PCSK-9 Antibody (Innovent Biologics)

Immunoglobulin igg2, anti-(human proprotein convertase subtilisin/kexin type 9) (human monoclonal ibi306 .gamma.2-chain), disulfide with human monoclonal ibi306 .kappa.-chain, dimer

Protein convertase subtilisin/kexin type 9 human monoclonal antibody(Innovent Biologics)

Recombinant Full-human Anti-PCSK-9 Monoclonal Antibody (Innovent)

Proprotein convertase subtilisin kexin type 9

Non ST segment elevation acute coronary syndrome


Multiple system atrophy, Parkinson's variant

United States
China
European Union
Japan
Canada
Australia
Brazil
Switzerland
Colombia
Israel
Iceland
South Korea
Liechtenstein
Norway


Heart failure with normal ejection fraction

Heart failure with reduced ejection fraction

Metabolic dysfunction-associated steatotic liver disease

Reduced ejection fraction co-occurrent and due to chronic heart failure

United States
China
European Union
Japan
Canada
Australia
Iceland
Liechtenstein
Norway


5-hydroxytryptamine receptors, ionotropic (HTR3)

Chemotherapy-induced nausea and vomiting

United States
China
European Union
Japan
United Kingdom
Australia
Iceland
Liechtenstein
Norway


Human immunodeficiency virus type 1 protease


Prednisolone sodium phosphate (JP17/USP)


Cefiderocol tosilate sulfate hydrate (JAN)

Carbapenem Resistant Bacterial Infection

Ventilator associated bacterial pneumonia

United States
China
Japan
United Kingdom
South Korea


Adalimumab biosimilar(Bio-Thera Solutions, Ltd.)

Polyarticular Juvenile Idiopathic Arthritis


United States
China
European Union
Japan
Iceland
Liechtenstein
Norway


United States
European Union
Japan
Iceland
Liechtenstein
Norway


Hormone Receptor Positive Breast Adenocarcinoma

Estrogen receptor positive breast cancer

Hormone receptor positive HER2 negative breast cancer

Locally Advanced Unresectable Breast Carcinoma

Metastatic human epidermal growth factor 2 positive carcinoma of breast

PIK3CA mutation/HR-positive/HER2-negative Breast Cancer

Hormone receptor positive Endometrial Carcinoma

PIK3CA mutated/HER2 Positive Breast Cancer

Hormone receptor positive HER2 positive breast cancer

GRPR Positive/ER Positive/HER2 Negative Breast Cancer

Human epidermal growth factor 2 negative carcinoma of breast

HR Positive/HER2 Negative/Node positive breast cancer

Metastatic HER2-Negative Breast Carcinoma

United States
China
European Union
Japan
Australia
Brazil
Iceland
Liechtenstein
Norway


Hypertrophic Cardiomyopathy without Obstruction


Tumor-associated calcium signal transducer 2

EGFR positive non-small cell lung cancer

PD-L1 positive Non-squamous non-small cell lung cancer

PD-L1 positive Triple Negative Breast Cancer

Metastatic Non-Squamous Non-Small Cell Lung Carcinoma

Locally Advanced Lung Non-Small Cell Carcinoma

Metastatic Triple-Negative Breast Carcinoma

Urothelial Carcinoma of the Urinary Bladder

Estrogen receptor positive breast cancer

Metastatic castration-resistant prostate cancer

Unresectable Lung Non-Small Cell Carcinoma

Advanced Triple-Negative Breast Carcinoma

Locally Advanced Lung Non-Squamous Non-Small Cell Carcinoma

Hormone receptor positive HER2 negative breast cancer

United States
China
European Union
Japan
Canada
Australia
Iceland
South Korea
Liechtenstein
Norway


Bevacizumab biosimilar (Innovent Biologics)

Advanced Lung Non-Squamous Non-Small Cell Carcinoma

Recurrent Lung Non-Squamous Non-Small Cell Carcinoma

Locally Advanced Malignant Solid Neoplasm

EGFR positive non-small cell lung cancer

EGFR positive Non-squamous non-small cell lung cancer


Japan
Australia
Belgium
South Korea
Luxembourg
Netherlands


United States
European Union
Canada
Iceland
Liechtenstein
Norway


Acetaminophen/Caffeine/Chlorpheniramine Maleate/Pseudoephedrine Hydrochloride/Methylephedrine Hydrochloride


GRPR Positive/ER Positive/HER2 Negative Breast Cancer

Metastatic human epidermal growth factor 2 positive carcinoma of breast

Metastatic Malignant Neoplasm to the Leptomeninges

Locally Advanced Unresectable Breast Carcinoma

Advanced Pancreatic Ductal Adenocarcinoma

Estrogen receptor positive breast cancer

HER2 positive Gastroesophageal Junction Adenocarcinoma

HER2 positive Gastrooesophageal junction cancer

Locally Advanced Gastroesophageal Junction Adenocarcinoma

Locally Advanced Hepatocellular Carcinoma

Locally Advanced Pancreatic Adenocarcinoma

Locally Advanced Unresectable Gastric Adenocarcinoma

Malignant neoplasm of gastro-oesophageal junction

Metastatic Gastroesophageal Junction Adenocarcinoma

Metastatic HER2 positive gastroesophageal junction cancer

Metastatic HER2-Negative Breast Carcinoma

Metastatic Pancreatic Ductal Adenocarcinoma

Metastatic Thyroid Gland Medullary Carcinoma

Recurrent Squamous Cell Carcinoma of the Head and Neck

Squamous cell carcinoma of head and neck metastatic

China
European Union
Japan
Australia
Iceland
Liechtenstein
Norway


Protein kinase AMP-activated non-catalytic subunit beta 1


Darbepoetin Alfa (Genetical Recombination)


Locally Advanced Lung Non-Small Cell Carcinoma

Interstitial lung disease due to systemic disease

Progressive fibrotic interstitial lung disease

Acute myeloid leukaemia with 11q23 abnormality

Platinum-Resistant Primary Peritoneal Carcinoma

Platinum-Sensitive Lung Small Cell Carcinoma

Recurrent Lung Non-Squamous Non-Small Cell Carcinoma

Unresectable Pleural Malignant Mesothelioma

United States
China
European Union
Japan
Australia
Iceland
South Korea
Liechtenstein
Norway


United States
China
European Union
Japan
United Kingdom
Canada
Australia
Switzerland
Iceland
South Korea
Liechtenstein
Norway


CD19-positive B-cell acute lymphoblastic leukemia

CD19 positive Acute Lymphoblastic Leukemia

CD19 positive Diffuse Large B-Cell Lymphoma

Chronic lymphocytic leukaemia refractory

Diffuse large B-cell lymphoma refractory

Precursor B-Cell Lymphoblastic Leukemia-Lymphoma


Nuclear factor erythroid 2-related factor 2

United States
European Union
United Kingdom
Canada
Australia
Iceland
Liechtenstein
Norway


Metastatic Pancreatic Ductal Adenocarcinoma

Locally Advanced Pancreatic Adenocarcinoma

Metastatic Esophageal Squamous Cell Carcinoma

Breast Carcinoma Metastatic in the Brain

Estrogen receptor positive breast cancer

Locally Advanced Gastroesophageal Junction Adenocarcinoma

Metastatic Gastroesophageal Junction Adenocarcinoma

Platinum-Resistant Fallopian Tube Carcinoma

Platinum-Resistant Primary Peritoneal Carcinoma


Erosive gastro-esophageal reflux disease


Pegfilgrastim  Biosimilar (Cipla Australia Pty Ltd.)


Chronic rhinosinusitis with nasal polyps

Progressive fibrotic interstitial lung disease

Moderate chronic obstructive pulmonary disease

Severe chronic obstructive pulmonary disease


Tc 99m-diethylenetriamine pentaacetic acid mannosyl dextran

Squamous cell carcinoma of the oral cavity

Cutaneous Squamous Cell Carcinoma of the Head and Neck

Metabolic Dysfunction Associated Steatohepatitis

Diagnostic radiopharmaceuticals
Radionuclide Drug Conjugates (RDC)


United States
China
European Union
Japan
United Kingdom
Australia
Iceland
South Korea
Liechtenstein
Norway


European Union
Iceland
South Korea
Liechtenstein
Norway


Chronic lymphocytic leukaemia refractory

United States
China
European Union
Japan
Canada
Iceland
South Korea
Liechtenstein
Norway


Inactivated SARS-CoV-2 vaccine (coronavirus disease 19 infection), Organization of Defensive Innovation and Research

Inactivated vaccine
Prophylactic vaccine


United States
European Union
United Arab Emirates
Iceland
Liechtenstein
Norway
Saudi Arabia


Denosumab Biosimilar (Samsung Bioepis Co., Ltd.)

Tumor necrosis factor ligand superfamily member 11

United States
European Union
Australia
Iceland
South Korea
Liechtenstein
Norway


United States
China
European Union
Japan
Australia
Iceland
Liechtenstein
Norway


Human Fibrinogen(Tonrol Biological Pharmaceutical)


Proto-oncogene tyrosine-protein kinase ROS

Reactive oxygen species 1 positive non-small cell lung cancer

Locally Advanced Lung Non-Small Cell Carcinoma


Romiplostim (genetical recombination) (JAN)

Chronic idiopathic thrombocytopenic purpura


Phosphodiesterases, 3',5'-cyclic nucleotide (PDEs)


Short Chain Acyl CoA Dehydrogenase Deficiency

Chronic thromboembolic pulmonary hypertension

United States
China
European Union
Japan
Canada
Switzerland
Iceland
South Korea
Liechtenstein
Norway


Anemia, Refractory, With Excess of Blasts


STT3 oligosaccharyltransferase complex catalytic subunit B

Resectable Lung Non-Small Cell Carcinoma

United States
China
Japan
United Kingdom
Australia
Austria
Belgium
Czechia
Denmark
Finland
Greece
Croatia
Hungary
Ireland
Italy
Netherlands
Poland
Portugal
Romania
Sweden
Slovenia


United States
China
Japan
Australia
Mexico


Renal angiomyolipoma with tuberous sclerosis complex

Hormone receptor positive HER2 negative breast cancer

Diffuse midline glioma, point mutation K27M in histone H3

Advanced Triple-Negative Breast Carcinoma

Recurrent Adult Acute Lymphoblastic Leukemia

Interstitial lung disease due to systemic disease

Advanced Gastroesophageal Junction Adenocarcinoma

Advanced Pancreatic Neuroendocrine Tumor

Blast Phase Chronic Granulocytic Leukemia

CD30-Positive recurrent or refractory Cutaneous T-Cell Lymphoma

Chronic lymphocytic leukaemia refractory

Desmoplastic Cerebral Astrocytoma of Infancy

Estrogen receptor positive breast cancer

Hormone receptor positive malignant neoplasm of breast

Large cell neuroendocrine carcinoma of lung

Locally Advanced Clear Cell Renal Cell Carcinoma

Locally Advanced Head and Neck Squamous Cell Carcinoma

Metastatic castration-resistant prostate cancer

Metastatic Clear Cell Renal Cell Carcinoma

Metastatic HER2-Negative Breast Carcinoma

Metastatic human epidermal growth factor 2 positive carcinoma of breast

Metastatic Triple-Negative Breast Carcinoma

Neuroendocrine neoplasm of gastrointestinal tract

Non Functioning Pancreatic Endocrine Tumor

Pancreatic neuroendocrine tumour metastatic

Recurrent Anaplastic Large Cell Lymphoma

Recurrent Squamous Cell Carcinoma of the Head and Neck

refractory acute lymphoid leukemia in relapse

Small cell neuroendocrine carcinoma of bladder

Squamous cell carcinoma of head and neck metastatic

Urothelial Carcinoma of the Urinary Bladder

Well Differentiated Pancreatic Endocrine Tumor

United States
China
European Union
Japan
Canada
Australia
Austria
Belgium
Bulgaria
Switzerland
Cyprus
Czechia
Germany
Denmark
Estonia
Spain
Finland
France
Greece
Croatia
Hungary
Ireland
Iceland
Italy
Liechtenstein
Lithuania
Luxembourg
Latvia
Malta
Netherlands
Norway
Poland
Portugal
Romania
Sweden
Slovenia
Slovakia


EGFR exon 19 Deletions Mutant Non-small Cell Lung Cancer

EGFR exon 21 Substitution Mutant Non-small Cell Lung Cancer

EGFR T790M Mutation Positive Non-Small Cell Lung Carcinoma

EGFR positive non-small cell lung cancer

Locally Advanced Malignant Solid Neoplasm

MET gene amplification Non-small Cell Lung Cancer

Locally Advanced Lung Non-Small Cell Carcinoma


United States
China
European Union
Japan
Iceland
Liechtenstein
Norway


Peripheral T-cell lymphoma unspecified recurrent

Peripheral T-cell lymphoma unspecified refractory

Locally Advanced Unresectable Gastric Adenocarcinoma

Metastatic castration-resistant prostate cancer


United States
China
Australia
Bulgaria
Switzerland


Chemotherapy-induced nausea and vomiting


Systemic onset juvenile chronic arthritis

Polyarticular Juvenile Idiopathic Arthritis


4 Factor Prothrombin Concentrate Complex - Octapharma

prothrombin complex concentrate, human-lans


Insulin aspart biosimilar(Gan & Lee Pharmaceuticals Co., Ltd.)

Insulin aspart Biosimilar (Gan & Lee Pharmaceuticals Co., Ltd.)


China
Japan
Australia
Czechia
Spain
France
Greece
Ireland
South Korea
Lithuania
Netherlands


United States
European Union
Japan
Canada
Australia
Iceland
South Korea
Liechtenstein
Norway


Insulin Glulisine (Genetical Recombination)

Insulin Glulisine (recombinant DNA origin)


United States
European Union
Japan
Canada
Iceland
Liechtenstein
Norway


Vascular endothelial growth factor receptor


Human epidermal growth factor 2 negative carcinoma of breast

Advanced Triple-Negative Breast Carcinoma

Estrogen receptor positive breast cancer

Estrogen receptor-negative breast cancer

Metastatic HER2-Negative Breast Carcinoma

Metastatic human epidermal growth factor 2 positive carcinoma of breast

Metastatic Triple-Negative Breast Carcinoma

progesterone receptor-negative breast cancer

United States
China
European Union
Japan
United Kingdom
Canada
Australia
India
Bosnia and Herzegovina
Bulgaria
Brazil
Switzerland
Germany
Estonia
Croatia
Hungary
Iceland
South Korea
Liechtenstein
Lithuania
Latvia
Mexico
Norway
Philippines
Poland
Romania
Serbia
Russia
Saudi Arabia
Singapore
Slovenia
Taiwan Province
Vietnam
South Africa


trans-1,2-Ethylenedicarboxylic acid dimethyl ester

Nuclear factor erythroid 2-related factor 2

Metabolic dysfunction-associated steatotic liver disease

Multiple Sclerosis, Secondary Progressive

Pulmonary arterial hypertension associated with connective tissue disease

United States
China
European Union
Japan
Australia
Iceland
South Korea
Liechtenstein
Norway


Durvalumab (genetical recombination) (JAN)

Unresectable Lung Non-Small Cell Carcinoma

Resectable Lung Non-Small Cell Carcinoma

Mismatch repair-deficient Endometrial Carcinoma

Locally Advanced Lung Non-Small Cell Carcinoma

PD-L1 positive Triple Negative Breast Cancer

Unresectable Esophageal Squamous Cell Carcinoma

PD-L1 positive Non-Small Cell Lung Cancer

Locally Advanced Hepatocellular Carcinoma

PD-L1 negative Triple Negative Breast Cancer

Non-Muscle Invasive Bladder Urothelial Carcinoma

high grade serous adenocarcinoma of ovary

HER2 positive Gastroesophageal Junction Adenocarcinoma

Advanced Triple-Negative Breast Carcinoma

Metastatic Clear Cell Renal Cell Carcinoma

Squamous Cell Carcinoma of Head and Neck

Locally Advanced Unresectable Gastric Adenocarcinoma

Locally Advanced Malignant Solid Neoplasm

Locally Advanced Pancreatic Adenocarcinoma

Urothelial Carcinoma of the Urinary Bladder

EGFR positive non-small cell lung cancer

HPV positive oropharyngeal squamous cell carcinoma

Locally Advanced Head and Neck Squamous Cell Carcinoma

Recurrent Platinum-Resistant Primary Peritoneal Carcinoma

Metastatic Non-Squamous Non-Small Cell Lung Carcinoma

Colorectal Cancer, Hereditary Nonpolyposis, Type 1

Microsatellite instability-high colorectal cancer

Metastatic castration-resistant prostate cancer

Metastatic Pancreatic Ductal Adenocarcinoma

Advanced Pancreatic Ductal Adenocarcinoma

Metastatic Triple-Negative Breast Carcinoma

Malignant neoplasm of gastro-oesophageal junction

Locally Advanced Gastroesophageal Junction Adenocarcinoma

Recurrent Squamous Cell Carcinoma of the Head and Neck

Secondary Central Nervous System Lymphoma

Estrogen receptor positive breast cancer

CD20 positive Diffuse Large B-Cell Lymphoma

Diffuse large B-cell lymphoma refractory

EGFR T790M Mutation Positive Non-Small Cell Lung Carcinoma

Hormone receptor positive malignant neoplasm of breast

Human Papillomavirus-Related Oropharyngeal Neoplasms

Metastatic Carcinoma to the Uterine Cervix

Metastatic Gastroesophageal Junction Adenocarcinoma

Metastatic human epidermal growth factor 2 positive carcinoma of breast

Metastatic Microsatellite Stable Colorectal Carcinoma

Platinum-Resistant Fallopian Tube Carcinoma

Platinum-Sensitive Lung Small Cell Carcinoma

Primary mediastinal large B-cell lymphoma recurrent

Primary mediastinal large B-cell lymphoma refractory

Recurrent Platinum-Resistant Ovarian Carcinoma

Small cell neuroendocrine carcinoma of bladder

Squamous cell carcinoma of head and neck metastatic

Squamous cell carcinoma of the hypopharynx

Squamous cell carcinoma of the oral cavity recurrent

Squamous cell carcinoma of the paranasal sinus

Transitional cell cancer of renal pelvis and ureter metastatic

Unresectable Pleural Malignant Mesothelioma

United States
China
European Union
Japan
United Kingdom
Canada
Australia
India
Brazil
Switzerland
Iceland
South Korea
Liechtenstein
Norway
Singapore


Hepatitis C virus serine protease, NS3/NS4A


BCMA-redirected autologous T cells-CARsgen

CAR-BCMA T cell therapy(CARsgen Therapeutics)


Sodium Rabeprazole Enteric-coated Tablets

Non-erosive gastro-esophageal reflux disease

United States
Japan
Austria
Belgium
Germany
Denmark
Spain
Finland
France
Greece
Ireland
Italy
South Korea
Luxembourg
Netherlands
Portugal
Sweden


European Union
Iceland
Liechtenstein
Norway


HRR Gene-mutated Castration-Resistant Prostate Cancer

Recurrent HER2-Negative Breast Carcinoma

BRCA Mutation Castration-Resistant Prostate Cancer

Germline BRCA-mutated Pancreatic Adenocarcinoma

Germline BRCA-mutated, HER2-negative metastatic breast cancer

Metastatic castration-resistant prostate cancer

Platinum-sensitive epithelial ovarian cancer

Platinum-Sensitive Fallopian Tube Carcinoma

Platinum-Sensitive Primary Peritoneal Carcinoma

Metastatic Non-Squamous Non-Small Cell Lung Carcinoma

Fallopian Tube Clear Cell Adenocarcinoma

high grade serous adenocarcinoma of ovary

Peripheral T-cell lymphoma unspecified refractory

Malignant neoplasm of gastro-oesophageal junction

Locally Advanced Head and Neck Squamous Cell Carcinoma

Metastatic HER2-Negative Breast Carcinoma

Hormone receptor positive HER2 negative breast cancer

Recurrent Squamous Cell Carcinoma of the Head and Neck

Squamous cell carcinoma of head and neck metastatic

Metastatic Pancreatic Ductal Adenocarcinoma

Metastatic Clear Cell Renal Cell Carcinoma

Recurrent Triple-Negative Breast Carcinoma

Locally Advanced Malignant Solid Neoplasm

Locally Advanced Pancreatic Adenocarcinoma

Recurrent Platinum-Resistant Primary Peritoneal Carcinoma

Metastatic Triple-Negative Breast Carcinoma

Unresectable Lung Non-Small Cell Carcinoma

Somatostatin Receptor-Positive Neuroendocrine Tumor

Advanced Triple-Negative Breast Carcinoma

Fallopian Tube High Grade Serous Adenocarcinoma

Locally Advanced Lung Non-Small Cell Carcinoma

Metastatic human epidermal growth factor 2 positive carcinoma of breast

Platinum-Resistant Fallopian Tube Carcinoma

Primary Peritoneal Serous Adenocarcinoma

Recurrent High Grade Fallopian Tube Serous Adenocarcinoma

Recurrent Platinum-Resistant Ovarian Carcinoma

Recurrent Primary Peritoneal High Grade Serous Adenocarcinoma

Squamous Cell Carcinoma of the Oropharynx

Urothelial Carcinoma of the Urinary Bladder

United States
China
European Union
Japan
United Kingdom
Canada
Australia
Iceland
South Korea
Liechtenstein
Norway


Hormone receptor positive HER2 negative breast cancer

Diffuse midline glioma, point mutation K27M in histone H3

Recurrent Low Grade Fallopian Tube Serous Adenocarcinoma

HR Positive/HER2 Negative/Node positive breast cancer

Estrogen receptor positive breast cancer

Hormone receptor positive HER2 positive breast cancer

Advanced Triple-Negative Breast Carcinoma

GRPR Positive/ER Positive/HER2 Negative Breast Cancer

Metastatic Triple-Negative Breast Carcinoma

Squamous Cell Carcinoma of Head and Neck

Squamous cell carcinoma of head and neck metastatic

Recurrent Adult Acute Lymphoblastic Leukemia

Non Functioning Pancreatic Endocrine Tumor

United States
China
European Union
United Kingdom
Canada
Australia
Switzerland
Iceland
South Korea
Liechtenstein
Norway


Hypoxia-inducible factor prolyl hydroxylase


Type 2 diabetes mellitus with established diabetic nephropathy

Non ST segment elevation acute coronary syndrome

United States
China
European Union
Japan
Australia
Iceland
Liechtenstein
Norway


Heart failure with normal ejection fraction

Idiopathic pulmonary arterial hypertension

Chronic Kidney Disease-Mineral and Bone Disorder


Metastatic castration-resistant prostate cancer

Non-Muscle Invasive Bladder Urothelial Carcinoma

AR-V7 positive Castration-Resistant Prostatic Cancer

Locally Advanced Head and Neck Squamous Cell Carcinoma

Metastatic HER2-Negative Breast Carcinoma

Renal Pelvis and Ureter Urothelial Carcinoma

United States
European Union
Japan
United Kingdom
Iceland
South Korea
Liechtenstein
Norway


Liraglutide Biosimilar (Teva Pharmaceuticals, Inc.)


Insulin lispro biosimilar (Jiangsu Wanbang Biopharma)


雷珠单抗生物类似药（Actor Pharmaceuticals Pty Ltd）

Ranibizumab  Biosimilar (Actor Pharmaceuticals Pty Ltd)

Proliferative retinopathy with diabetes mellitus

Retinal vein occlusion-related macular edema


Attention Deficit Disorder With Hyperactivity


Insulin glargine (Tianmai Biotechnology)

Insulin glargine  Biosimilar (Hefei Tianmai Biotechnology Development Co., Ltd.)

甘精胰岛素生物类似药（Hefei Tianmai Biotechnology Development Co., Ltd.）


United States
China
Japan
Australia
Germany
France
Netherlands


Darbepoetin alfa Biosimilar (Dong-A Pharmaceutical Co., Ltd.)

达依泊汀α 生物类似药（Dong-A Pharmaceutical Co., Ltd.）


caseinolytic mitochondrial matrix peptidase proteolytic subunit

Diffuse midline glioma, point mutation K27M in histone H3

Refractory Adult Acute Lymphoblastic Leukemia

Advanced Triple-Negative Breast Carcinoma

Hormone receptor positive HER2 negative breast cancer

Metastatic Microsatellite Stable Colorectal Carcinoma

Metastatic Triple-Negative Breast Carcinoma

Recurrent Childhood Acute Lymphoblastic Leukemia


Anti-IL-4Rα recombinant fully humanized antibody

Recombinant humannized monoclonal antibody (Keymed Biosciences, Inc.)

Chronic rhinosinusitis with nasal polyps


Coagulation Factor IX (Recombinant), GlycoPEGylated

Nonacog Beta Pegol (Genetical Recombination)

Nonacog beta pegol (genetical recombination) (JAN)

United States
European Union
Japan
Canada
Australia
Iceland
Liechtenstein
Norway


Omalizumab (genetical recombination) (JAN)

Recombinant human monoclonal antibody E25


Recombinant human thyroid stimulating hormone(SmartNuclide)


Instant release (IR) tolperisone tablets - Sanochemia

Sustained release tolperisone tablets - Sanochemia

Sodium voltage-gated channel alpha subunits

Multiple Sclerosis, Secondary Progressive

China Japan Switzerland Germany Russia Thailand Ukraine


Hydrocortisone hydrogen succinate(Laboratoire Aguettant)

Hydrocortisone sodium succinate (JP17/USP)


United States
China
European Union
Japan
United Kingdom
Iceland
Liechtenstein
Norway


Polyarticular Juvenile Idiopathic Arthritis

United States
European Union
Canada
Iceland
Liechtenstein
Norway


Antihemophilic Factor (Recombinant BDD), FC Fusion Protein

Antihemophilic Factor (Recombinant), Fc Fusion protein

Antihemophilic factor (recombinant, FC fusion protein)

Coagulation factor VIII recombinant immunoglubulin g1 fusion protein

Efraloctocog Alfa (Genetical Recombination)

Fc fusion protein
Recombinant coagulation factor

United States
European Union
Japan
Australia
Iceland
Liechtenstein
Norway


China
European Union
Canada
Iceland
Liechtenstein
Norway


Adalimumab biosimilar(Coherus BioSciences, Inc.)


Clostridium botulinum toxin type A (PROTOX)


N-[3-[(4-amino-6,7-dimethoxy-quinazolin-2-yl)- methyl-amino]propyl] tetrahydrofuran- 2-carboxamide


Proprotein convertase subtilisin kexin type 9

United States
China
European Union
Japan
Canada
Australia
Iceland
South Korea
Liechtenstein
Norway


CD19-positive B-cell acute lymphoblastic leukemia

Precursor B-Cell Lymphoblastic Leukemia-Lymphoma

Metastatic castration-resistant prostate cancer

Metastatic Pancreatic Ductal Adenocarcinoma

Recurrent Childhood Acute Lymphoblastic Leukemia

Philadelphia positive acute lymphocytic leukaemia

Aggressive-Phase Chronic Myelocytic Leukemia

Blast Phase Chronic Granulocytic Leukemia

Metastatic HER2-Negative Breast Carcinoma

Metastatic human epidermal growth factor 2 positive carcinoma of breast

Philadelphia Chromosome Positive Leukemia

Philadelphia chromosome-positive acute lymphoblastic leukemia in relapse

Recurrent Squamous Cell Carcinoma of the Head and Neck

Squamous Cell Carcinoma of Head and Neck

Steroid Refractory Graft Versus Host Disease

United States
China
European Union
Japan
United Kingdom
Canada
Australia
Hong Kong
Iceland
Liechtenstein
Macao
Norway


Polyarticular Juvenile Idiopathic Arthritis


Epoetin alfa biosimilar (PanGen Biotech)

Epoetin Alfa Biosimilar (PanGen Biotech, Inc.)


Recurrent Platinum-Resistant Fallopian Tube Carcinoma

Recurrent Platinum-Resistant Ovarian Carcinoma

Recurrent Platinum-Resistant Primary Peritoneal Carcinoma

Platinum-Resistant Epithelial Ovarian Carcinoma


Basiliximab (genetical recombination) (JAN)

United States
China
European Union
Japan
Iceland
Liechtenstein
Norway


A thienopyrimidine derivative that preferentially inhibits Phosphodiesterase 4B

Progressive fibrotic interstitial lung disease


Recombinant human albumin(Shanghai Anruite)


Mouse nerve growth factor(Staidson (Beijing) Biopharmaceuticals Co., Ltd.)

Low affinity neurotrophin receptor p75NTR


Anti-CD20/CD3 T-cell dependent bispecific antibody

Diffuse large B-cell lymphoma refractory

Recurrent Transformed Follicular Lymphoma to Diffuse Large B-Cell Lymphoma

Refractory Aggressive Non-Hodgkin Lymphoma

Refractory Transformed Follicular Lymphoma to Diffuse Large B-Cell Lymphoma

C-Myc positive High grade B-cell lymphoma

High grade B-cell lymphoma with MYC and BCL2 and/or BCL6 rearrangements

Chronic lymphocytic leukaemia refractory

Refractory B Acute Lymphoblastic Leukemia

United States
China
European Union
Japan
Canada
Iceland
Liechtenstein
Norway


Losartan Potassium/Ezetimibe/Amlodipine Besylate/Rosuvastatin Calcium


high grade serous adenocarcinoma of ovary


Peroxisome proliferator-activated receptor α


KRAS G12C mutant Non-small Cell Lung Cancer

Resectable Lung Non-Small Cell Carcinoma

Locally Advanced Lung Non-Small Cell Carcinoma

KRAS G12C mutant non-squamous non-small cell lung cancer


United States
European Union
Japan
Canada
Australia
Iceland
South Korea
Liechtenstein
Norway


Avelumab (genetical recombination) (JAN)

PD-L1 positive Gastroesophageal junction adenocarcinoma

Urothelial Carcinoma of the Urinary Bladder

Estrogen receptor positive breast cancer

Metastatic human epidermal growth factor 2 positive carcinoma of breast

Muscle Invasive Bladder Urothelial Carcinoma

Human Papillomavirus-Related Anal canal squamous cell carcinoma

Human Papillomavirus-Related Squamous Cell Carcinoma of the Penis

Advanced Triple-Negative Breast Carcinoma

Metastatic Malignant Neoplasm to the Leptomeninges

CD20 positive Diffuse Large B-Cell Lymphoma

Diffuse large B-cell lymphoma refractory

Hormone Receptor Positive Breast Adenocarcinoma

Locally Advanced Head and Neck Squamous Cell Carcinoma

Locally Advanced Malignant Solid Neoplasm

Malignant neoplasm of gastro-oesophageal junction

Metastatic castration-resistant prostate cancer

Metastatic Clear Cell Renal Cell Carcinoma

Metastatic Pancreatic Ductal Adenocarcinoma

Microsatellite instability-high colorectal cancer

Pancreatic neuroendocrine tumour metastatic

PD-L1 positive Non-Small Cell Lung Cancer

Squamous Cell Carcinoma of Head and Neck

Squamous cell carcinoma of head and neck metastatic

Unresectable Esophageal Squamous Cell Carcinoma


Evolocumab (genetical recombination) (JAN)

Proprotein convertase subtilisin kexin type 9

United States
China
European Union
Japan
Canada
Australia
Switzerland
Iceland
Liechtenstein
Norway


high grade serous adenocarcinoma of ovary

Metastatic human epidermal growth factor 2 positive carcinoma of breast

Recurrent Low Grade Fallopian Tube Serous Adenocarcinoma

Hormone receptor positive HER2 negative breast cancer

PIK3CA mutated/HER2 Positive Breast Cancer

Locally Advanced Unresectable Breast Carcinoma

Hormone receptor positive HER2 positive breast cancer

Estrogen receptor positive breast cancer

Hormone Receptor Positive Breast Adenocarcinoma

Hormone receptor positive Endometrial Carcinoma

HR Positive/HER2 Negative/Node positive breast cancer

Human epidermal growth factor 2 negative carcinoma of breast

United States
China
Japan
Switzerland
Sweden


Cystic fibrosis transmembrane conductance regulator

United States
European Union
United Kingdom
Canada
Australia
Switzerland
Iceland
Liechtenstein
Norway
New Zealand


FGFR2 fusion or rearranged Cholangiocarcinoma


Recombinant human granulocyte-macrophage colony stimulating factor

Granulocyte-macrophage colony-stimulating factor receptor

Hematopoietic subsyndrome of acute radiation syndrome

Pulmonary Alveolar Proteinosis, Acquired

CD20 Positive B-Cell Non-Hodgkin Lymphoma

Pulmonary Alveolar Proteinosis, Congenital

recurrent primary peritoneal cavity cancer

Transitional cell cancer of renal pelvis and ureter metastatic

Urothelial Carcinoma of the Urinary Bladder

United States
European Union
Japan
Iceland
Liechtenstein
Norway


Folate receptor-alpha positive, platinumresistant epithelial ovarian cancer

Non-Functioning Pituitary Neuroendocrine Tumor


Bupivacaine hydrochloride hydrate (JP17)

Sodium voltage-gated channel alpha subunits


重组新型冠状病毒融合蛋白二价（原型株/Omicron XBB变异株）疫苗（CHO 细胞）

Recombinant Covid-19 Fusion Protein 2-valent (Protostrain/Omicron XBB mutant strain) Vaccine (CHO cell)


United States
European Union
Japan
Canada
United Arab Emirates
Iceland
South Korea
Liechtenstein
Norway
Saudi Arabia


Metabolic Dysfunction Associated Steatohepatitis


United States
European Union
Japan
Canada
Australia
Brazil
Switzerland
Iceland
South Korea
Liechtenstein
Norway


Induced termination of pregnancy in second trimester

Metastatic Triple-Negative Breast Carcinoma


Polyethylene glycol recombinant human somatropin(Changchun Genescience)


Non-erosive gastro-esophageal reflux disease

Erosive gastro-esophageal reflux disease


Metastatic Carcinoma to the Uterine Cervix

Hepatitis B Virus-Related Hepatocellular Carcinoma

Resectable Lung Non-Small Cell Carcinoma

Metastatic Non-Squamous Non-Small Cell Lung Carcinoma

PD-L1 positive Non-Small Cell Lung Cancer

Advanced Pancreatic Ductal Adenocarcinoma

Locally Advanced Pancreatic Adenocarcinoma

Metastatic Pancreatic Ductal Adenocarcinoma

Locally Advanced Lung Non-Small Cell Carcinoma

Recurrent Squamous Cell Carcinoma of the Head and Neck

Squamous cell carcinoma of head and neck metastatic

Locally Advanced Clear Cell Renal Cell Carcinoma

Locally Advanced Gastroesophageal Junction Adenocarcinoma

Malignant neoplasm of gastro-oesophageal junction

Metastatic castration-resistant prostate cancer

Metastatic Gastroesophageal Junction Adenocarcinoma

Squamous cell carcinoma of the hypopharynx

Squamous cell carcinoma of the oral cavity

Squamous Cell Carcinoma of the Oropharynx


JAK-2 V617F Positive Myeloproliferative Disorders

Polyarticular Juvenile Idiopathic Arthritis

Systemic onset juvenile chronic arthritis

United States
European Union
United Kingdom
Iceland
Liechtenstein
Norway


Omalizumab Biosimilar (Taizhou Mabtech Pharmaceutical Co. Ltd.)


EGFR T790M Mutation Positive Non-Small Cell Lung Carcinoma


Ventilator associated bacterial pneumonia


United States
European Union
Canada
Australia
Iceland
Liechtenstein
Norway


United States
China
European Union
Japan
United Kingdom
Canada
Australia
Iceland
Liechtenstein
Norway


Squamous Cell Carcinoma of Head and Neck

Locally Advanced Head and Neck Squamous Cell Carcinoma

Locally Advanced Pancreatic Adenocarcinoma

EGFR positive Gastrooesophageal junction cancer

Locally Advanced Cutaneous Squamous Cell Carcinoma of the Head and Neck

Locally Advanced Esophageal Squamous Cell Carcinoma

Metastatic Esophageal Squamous Cell Carcinoma

Recurrent Triple-Negative Breast Carcinoma

China India Indonesia Philippines Thailand Ukraine


Refractory Acute Graft Versus Host Disease

Steroid Refractory Graft Versus Host Disease


68Ga-PSMA-R2(Advanced Accelerator Applications SA)

Gallium Ga 68-labeled psma ligand Glu-urea-Lys(ahx)-hbed-CC

PSMA-Positive Castration-Resistant Prostatic Cancer

Metastatic castration-resistant prostate cancer

Peptide Conjugate Radionuclide
Diagnostic radiopharmaceuticals

United States
China
European Union
Japan
United Kingdom
Canada
Australia
Germany
France
Iceland
Liechtenstein
Norway


Platelet-derived growth factor receptor alpha

United States
China
European Union
United Kingdom
Canada
Australia
Switzerland
Hong Kong
Israel
Iceland
Liechtenstein
Norway
New Zealand
Singapore
Taiwan Province


特立帕肽生物类似药(Sun Pharmaceutical Industries Ltd.)

Teriparatide biosimilar(Sun Pharmaceutical Industries Ltd.)

European Union
Australia
Iceland
Liechtenstein
Norway


United States
China
European Union
Japan
Canada
Australia
Switzerland
Iceland
South Korea
Liechtenstein
Norway


Metabolic dysfunction-associated steatotic liver disease

United States
China
European Union
Japan
Australia
Iceland
Liechtenstein
Norway


Recombinant COVID-19 Vaccine (CHO cell, NVSI-06-09)

Recombinant protein
Prophylactic vaccine


Dual specificity mitogen-activated protein kinase kinase 1

Dual specificity mitogen-activated protein kinase kinase 2


China
European Union
Japan
Canada
Australia
Switzerland
Iceland
South Korea
Liechtenstein
Norway


Recombinant humanized anti-IL17A monoclonal antibody (Sunshine Guojian )


Irritable bowel syndrome with constipation


Hepatitis C virus serine protease, NS3/NS4A


Hypertrophic Cardiomyopathy without Obstruction

Type 2 diabetes mellitus with established diabetic nephropathy

United States
China
Japan
Australia
Brazil


Platinum-Resistant Epithelial Ovarian Carcinoma

Platinum-Resistant Fallopian Tube Carcinoma

Platinum-Resistant Primary Peritoneal Carcinoma

Metastatic Pancreatic Ductal Adenocarcinoma


Aflibercept Biosimilar (Boan Biological)

Aflibercept Biosimilar (Shandong Boan Biotechnology Co., Ltd.)


Systemic onset juvenile chronic arthritis

Interstitial lung disease due to connective tissue disease

Interstitial lung disease due to systemic disease

Rheumatoid arthritis with rheumatoid lung disease

Polyarticular Juvenile Idiopathic Arthritis


Hepatitis B Virus-Related Hepatocellular Carcinoma


United States
European Union
Iceland
Liechtenstein
Norway


Heart failure with reduced ejection fraction


Hormone receptor positive HER2 negative breast cancer

Metastatic castration-resistant prostate cancer

Estrogen receptor positive breast cancer

Hormone Receptor Positive Breast Adenocarcinoma

Metastatic Triple-Negative Breast Carcinoma

United States
China
European Union
Japan
United Kingdom
Canada
Australia
Iceland
South Korea
Liechtenstein
Norway


China
European Union
Japan
Australia
Iceland
Liechtenstein
Norway


Sleep Initiation and Maintenance Disorders

United States
China
European Union
Japan
United Kingdom
Canada
Switzerland
Hong Kong
Iceland
Liechtenstein
Norway
Taiwan Province


United States
China
Germany
Spain
France
Italy
Netherlands
Portugal


5-hydroxytryptamine receptors, ionotropic (HTR3)

Attention Deficit Disorder With Hyperactivity

Major depressive disorder, moderate (MDD)

United States
China
European Union
Japan
Canada
Australia
India
Brazil
Switzerland
Iceland
South Korea
Liechtenstein
Norway


Small intestine transplantation rejection

Thrombotic Thrombocytopenic Purpura, Acquired

CD20 Positive B-Cell Chronic Lymphocytic Leukemia

Chronic idiopathic thrombocytopenic purpura

CD20 Positive B-Cell Non-Hodgkin Lymphoma

CD20 positive Diffuse Large B-Cell Lymphoma

Chronic lymphocytic leukaemia refractory

T-cell/histiocyte rich large B-cell lymphoma

Philadelphia positive acute lymphocytic leukaemia

Precursor B-Cell Lymphoblastic Leukemia-Lymphoma

Epstein-Barr virus associated Diffuse Large B-Cell Lymphoma

Primary cutaneous diffuse large cell B-cell lymphoma

Recurrent T-Cell/Histiocyte-Rich Large B-Cell Lymphoma

Refractory Diffuse Large B-Cell Lymphoma Activated B-Cell Type

Refractory Intravascular Large B-Cell Lymphoma

Refractory T-Cell/Histiocyte-Rich Large B-Cell Lymphoma

CD19-positive B-cell acute lymphoblastic leukemia

Philadelphia Chromosome Negative Acute Lymphoblastic Leukemia

Primary mediastinal large B-cell lymphoma recurrent

Primary mediastinal large B-cell lymphoma refractory

Refractory Transformed Indolent B-Cell Non-Hodgkin Lymphoma

Secondary Central Nervous System Lymphoma

CCUS Clonal Cytopenia of Undetermined Significance

Diffuse large B-cell lymphoma refractory

Acute myeloid leukaemia with 11q23 abnormality

Acute Myeloid Leukemia with Myelodysplasia-Related Changes

Aggressive-Phase Chronic Myelocytic Leukemia

Anemia, Refractory, With Excess of Blasts

High grade B-cell lymphoma with MYC and BCL2 and/or BCL6 rearrangements

Refractory Adult Acute Lymphoblastic Leukemia

Locally Advanced Malignant Solid Neoplasm

Burkitt-like lymphoma with 11q aberration

Recurrent Transformed B-Cell Non-Hodgkin Lymphoma

Recurrent B Acute Lymphoblastic Leukemia

Recurrent Mixed Phenotype Acute Leukemia

Recurrent Central Nervous System Lymphoma

Refractory Central Nervous System Lymphoma

AIDS-Related Diffuse Large Cell Lymphoma

Blast Phase Chronic Granulocytic Leukemia

CD22 positive Acute Lymphoblastic Leukemia

Congenital Thrombotic Thrombocytopenic Purpura

EBV-Related Post-Transplant Lymphoproliferative Disorder

Monoclonal Gammopathy of Undetermined Significance

Multiple Sclerosis, Secondary Progressive

pediatric lymphoblastic non-Hodgkin's lymphoma

Philadelphia chromosome positive chronic myelogenous leukemia

Polyradiculoneuropathy, Chronic Inflammatory Demyelinating

Primary Cutaneous Anaplastic Large Cell Lymphoma

Recurrent Adult Acute Lymphoblastic Leukemia

Recurrent Adult Grade III Lymphomatoid Granulomatosis

Recurrent Aggressive Non-Hodgkin Lymphoma

Recurrent Anaplastic Large Cell Lymphoma

Recurrent Childhood Acute Lymphoblastic Leukemia

Recurrent High-Grade B-Cell Lymphoma with MYC and BCL2 or BCL6 Rearrangements

Recurrent Ph-Like Acute Lymphoblastic Leukemia

Recurrent Transformed Chronic Lymphocytic Leukemia

Recurrent Transformed Follicular Lymphoma to Diffuse Large B-Cell Lymphoma

Refractory Acute Undifferentiated Leukemia

Refractory Aggressive Non-Hodgkin Lymphoma

Refractory B Acute Lymphoblastic Leukemia

Refractory Indolent Adult Non-Hodgkin Lymphoma

Refractory Indolent Non-Hodgkin Lymphoma

Refractory Ph-Like Acute Lymphoblastic Leukemia

Refractory Transformed Chronic Lymphocytic Leukemia

Refractory Transformed Follicular Lymphoma to Diffuse Large B-Cell Lymphoma

Rheumatoid arthritis with rheumatoid lung disease

Stage II Non-Contiguous Adult Diffuse Small Cleaved Cell Lymphoma

Steroid Refractory Graft Versus Host Disease

Subcutaneous Panniculitis-Like T-Cell Lymphoma

United States
China
European Union
Japan
Canada
Australia
India
Switzerland
Iceland
South Korea
Liechtenstein
Norway
Taiwan Province


Pegylated Human Granulocyte Colony-stimulating Factor (SL Pharmaceutical)

Pegfilgrastim biosimilar (SL Pharmaceutical)


PD-L1 positive Non-Small Cell Lung Cancer


Betahistine Hydrochloride Sodium Chloride

Betahistine Hydrochloride and Sodium Chloride

Betahisting Hydrochloride and Sodium Chloride


Etanercept biosimilar (Qilu Pharmaceutical)

Recombinant human type II tumor necrosis factor receptor-antibody fusion protein(Qilu Pharmaceutical)


Levofloxacin Hydrochloride and Sodium Chloride

Levofloxacin Lactate and Chloride Sodium lnjection

Levofloxacin Lactate and Sodium Chloeide

Levofloxacin Lactate and Sodium Chloride

Levofloxacin Lactate and Sodium Cholride

Levofloxacin Mesilate and Sodium Chloride

Levofloxacin Mesylate and Sodium Chloride

Levofloxacine Lactate and Chloride Sodium

Levofloxacine Lactate and Sodium Chloride

Complicated skin and skin structure infection

Non-complicated skin and skin structure infection

China
European Union
Japan
Iceland
Liechtenstein
Norway


Alteplase (genetical recombination) (JAN)

Plasminogen activator (human tissue-type protein moiety)

Recombinant tissue plasminogen activator

Tissue plasminogen activator, recombinant


Refractory Central Nervous System Lymphoma

Chronic lymphocytic leukaemia refractory


Metastasis from malignant tumor of prostate

United States
European Union
United Kingdom
Canada
Australia
Iceland
Liechtenstein
Norway


Hypoxia-inducible factor prolyl hydroxylase


Mirikizumab (genetical recombination) (JAN)

United States
China
European Union
Japan
United Kingdom
Canada
Australia
Switzerland
Iceland
South Korea
Liechtenstein
Norway


Cetuximab (genetical recombination) (JAN)

Squamous Cell Carcinoma of Head and Neck

Recurrent Squamous Cell Carcinoma of the Head and Neck

Squamous cell carcinoma of head and neck metastatic

Locally Advanced Malignant Solid Neoplasm

Metastatic Microsatellite Stable Colorectal Carcinoma

Locally Advanced Esophageal Squamous Cell Carcinoma

KRAS G12C mutant Non-small Cell Lung Cancer

EGFR positive non-small cell lung cancer

EGFR T790M Mutation Positive Non-Small Cell Lung Carcinoma

HER2 negative Gastroesophageal Junction Adenocarcinoma

HPV positive oropharyngeal squamous cell carcinoma

Locally Advanced Cutaneous Squamous Cell Carcinoma of the Head and Neck

Locally Advanced Head and Neck Squamous Cell Carcinoma

Locally Advanced Lung Non-Small Cell Carcinoma

Locally Advanced Pancreatic Adenocarcinoma

Metastatic Gastroesophageal Junction Adenocarcinoma

Metastatic Non-Squamous Non-Small Cell Lung Carcinoma

Metastatic Triple-Negative Breast Carcinoma

Platinum-Resistant Primary Peritoneal Carcinoma

Platinum-Sensitive Primary Peritoneal Carcinoma

Renal Pelvis and Ureter Urothelial Carcinoma

Squamous cell carcinoma of the hypopharynx

Squamous cell carcinoma of the oral cavity

Squamous Cell Carcinoma of the Oropharynx

Squamous cell carcinoma of the paranasal sinus

Unresectable Lung Non-Small Cell Carcinoma

Urothelial Carcinoma of the Urinary Bladder

United States
China
European Union
Japan
Australia
Switzerland
Iceland
Liechtenstein
Norway


Acute Myeloid Leukemia with FLT3/ITD Mutation

refractory acute lymphoid leukemia in relapse

Treatment related acute myeloid leukaemia

United States
European Union
Japan
United Kingdom
Canada
Iceland
South Korea
Liechtenstein
Norway


Dry powder formulation of treprostinil(MannKind Corporation)

Chronic thromboembolic pulmonary hypertension

Pulmonary hypertension due to interstitial lung disease

Progressive fibrotic interstitial lung disease

Idiopathic pulmonary arterial hypertension

pulmonary hypertension due to lung diseases and hypoxia

Combined pulmonary fibrosis and emphysema

Heart failure with normal ejection fraction

Pulmonary arterial hypertension associated with connective tissue disease

United States
China
European Union
Japan
Austria
Belgium
Cyprus
Czechia
Germany
Denmark
Estonia
Finland
France
Global
Greece
Hungary
Iceland
Italy
South Korea
Liechtenstein
Lithuania
Luxembourg
Latvia
Netherlands
Norway
Poland
Portugal
Sweden
Slovenia
Slovakia


Locally Advanced Head and Neck Squamous Cell Carcinoma

Squamous Cell Carcinoma of Head and Neck

EGFR positive non-small cell lung cancer

Metastatic Gastroesophageal Junction Adenocarcinoma

Squamous cell carcinoma of head and neck metastatic


Heparin-induced thrombocytopenia and thrombosis


Adalimumab biosimilar (Sinocelltech Group)

Recombinant human TNF-α monoclonal antibody(Sinocelltech Group)

Polyarticular Juvenile Idiopathic Arthritis


United States
China
United Kingdom
Australia
Austria
Belgium
Switzerland
Cyprus
Czechia
Germany
Denmark
Spain
Finland
France
Greece
Hungary
Ireland
Iceland
Italy
Luxembourg
Malta
Netherlands
Norway
Poland
Portugal
Sweden
Slovenia
Slovakia


United States
China
European Union
United Kingdom
Canada
United Arab Emirates
Israel
Iceland
Kuwait
Liechtenstein
Norway
Saudi Arabia


KRAS G12C mutant Non-small Cell Lung Cancer

Locally Advanced Malignant Solid Neoplasm

KRAS G12C mutant non-squamous non-small cell lung cancer


Varicella Vaccine, Live (Beijing Minhai Biological )

Freeze-dried live attenuated varicella vaccine (Beijing Minhai Biological )

Live attenuated vaccine
Prophylactic vaccine


China Canada Belgium Czechia Germany Slovakia


SARS-CoV-2 mRNA Vaccine (Variants) (Walvax Biotechnology)


Recombinant human serum albuminfrom OsrHSA (Wuhan Healthgen)

Recombinant Human SerumAlbumin from Oryza Sativa

Recombinant human serum albumin (Wuhan Healthgen)


Metabolic dysfunction-associated steatotic liver disease

Metabolic Dysfunction Associated Steatohepatitis


对乙酰氨基酚/马来酸氯苯那敏/无水咖啡因/盐酸伪麻黄碱/盐酸DL-甲基麻黄碱/氢溴酸右美沙芬水合物/愈创甘油醚

Acetaminophen/Chlorpheniramine Maleate/Anhydrous Caffeine/Pseudoephedrine Hydrochloride/DL-Methylephedrine Hydrochloride/Dextromethorphan Hydrobromide Hydrate/Guaifenesin


Hypoxia-inducible factor prolyl hydroxylase


CD20 Positive B-Cell Non-Hodgkin Lymphoma


1-24-Corticotropin - Travere Therapeutics

Adrenocorticotropic hormone fragment 1-24 human, rat

Multiple Sclerosis, Secondary Progressive


Fosravuconazole L-lysine ethanolate (JAN)


Denosumab biosimilar(Intas Biopharmaceuticals Ltd.)

Denosumab Biosimilar (Intas Biopharmaceuticals Ltd.)

Tumor necrosis factor ligand superfamily member 11

United States
European Union
Australia
Iceland
Liechtenstein
Norway


United States
European Union
Iceland
Liechtenstein
Norway


Human prothrombin complex (Guangdong Shuanglin)


Abciximab (genetical recombination) (JAN)


Chemotherapy-induced nausea and vomiting

United States
China
United Kingdom
Australia


Human Prothrombin Complex Concentrate(Shanxi Kangbao Biological Products)


Sodium channel protein type X alpha subunit


United States
European Union
Japan
Canada
Australia
Iceland
Liechtenstein
Norway


Advanced Head and Neck Squamous Cell Carcinoma

Metastatic castration-resistant prostate cancer

Metastatic Digestive System Neuroendocrine Tumor G1

Recurrent Adult Acute Lymphoblastic Leukemia

Recurrent Central Nervous System Lymphoma

Refractory Central Nervous System Lymphoma

Squamous cell carcinoma of head and neck metastatic

United States
European Union
Japan
Iceland
South Korea
Liechtenstein
Norway


Mouse nerve growth factor(Wuhan Hiteck Biological Pharma Co., Ltd.)

Low affinity neurotrophin receptor p75NTR


Protein kinase AMP-activated non-catalytic subunit beta 1

Heart failure with normal ejection fraction

Multiple Sclerosis, Secondary Progressive

Chronic lymphocytic leukaemia refractory

Hereditary Leiomyomatosis and Renal Cell Cancer

Locally Advanced Lung Non-Small Cell Carcinoma

Locally Advanced Pancreatic Adenocarcinoma

Metabolic Dysfunction Associated Steatohepatitis

Metabolic dysfunction-associated steatotic liver disease

Metastatic Microsatellite Stable Colorectal Carcinoma

Papillary Renal Cell Carcinoma, Sporadic

recurrent primary peritoneal cavity cancer


Immunoglobulin G1, anti-(human interleukin 36 receptor) (humanized monoclonal BI 655130 gamma1-chain), disulfide with humanized monoclonal BI 655130 kappa-chain, dimer

Spesolimab (genetical recombination) (JAN)

United States
China
European Union
Japan
Canada
Australia
Iceland
South Korea
Liechtenstein
Norway


Granulocyte-macrophage colony-stimulating factor receptor

Locally Advanced Head and Neck Squamous Cell Carcinoma

Metastatic Triple-Negative Breast Carcinoma

Non-Muscle Invasive Bladder Urothelial Carcinoma

Recurrent HER2-Negative Breast Carcinoma

Recurrent Squamous Cell Carcinoma of the Head and Neck

Squamous cell carcinoma of head and neck metastatic


United States
China
European Union
Japan
Canada
Australia
Iceland
Liechtenstein
Norway


Immunoglobulin g1-kappa, anti-(homo sapiens ms4a1 (membrane-spanning 4-domains subfamily a member 1, cd20)), chimeric monoclonal antibody

Immunoglobulin igg1, anti-(human cd20 antigen) (human-mus musculus monoclonal disulfide sct400 .gamma.1-chain), disulfide with human-mus musculus monoclonal sct400 .kappa.-chain, dimer

Recombinant chimeric anti-CD20 monoclonal antibody(Sino Cell Technologies, Inc.)

CD20 Positive B-Cell Non-Hodgkin Lymphoma

CD20 positive Diffuse Large B-Cell Lymphoma


RET Mutation-Positive Medullary Thyroid Cancer

RET fusion-positive Non-Small Cell Lung Cancer

Advanced Thyroid Gland Medullary Carcinoma

RET fusion-positive  Adenocarcinoma of Lung

United States
China
Australia
Switzerland
Hong Kong
Taiwan Province


Ranibizumab biosimilar (Xbrane Biopharma)

Ranibizumab  Biosimilar (Xbrane Biopharma AB)

Retinal vein occlusion-related macular edema

European Union
Iceland
Liechtenstein
Norway


Metastatic HER2-Negative Breast Carcinoma

Metastatic human epidermal growth factor 2 positive carcinoma of breast

Metastatic Malignant Neoplasm to the Leptomeninges

HER2 positive Gastroesophageal Junction Adenocarcinoma

HER2-Low Gastroesophageal Junction Cancer

Locally Advanced Unresectable Breast Carcinoma

Hormone receptor positive HER2 positive breast cancer

Locally Advanced Malignant Solid Neoplasm

HER2 Positive Gastrointestinal Neoplasms

PIK3CA mutated/HER2 Positive Breast Cancer

HER2 Positive Gastroesophageal Adenocarcinoma

Locally Advanced Gastroesophageal Junction Adenocarcinoma

United States
European Union
Japan
United Kingdom
Canada
Australia
Switzerland
Iceland
Liechtenstein
Norway
Singapore


Ranibizumab  Biosimilar (Qilu Pharmaceutical Co., Ltd./PHARMARESEARCH BIO Co., Ltd.)

雷珠单抗生物类似药（Qilu Pharmaceutical Co., Ltd./PHARMARESEARCH BIO Co., Ltd.）

Proliferative retinopathy with diabetes mellitus

China
European Union
Iceland
Liechtenstein
Norway


Human Coagulation Factor IX (Shandong Taibang)


Gene therapy
Hematopoietic stem cell therapy


Aggressive-Phase Chronic Myelocytic Leukemia

SDH-deficient Gastrointestinal Stromal Tumors

Philadelphia chromosome positive chronic myelogenous leukemia

Philadelphia positive acute lymphocytic leukaemia

Philadelphia chromosome-positive acute lymphoblastic leukemia in relapse

Philadelphia Chromosome Positive Acute Myeloid Leukemia

Precursor B-Cell Lymphoblastic Leukemia-Lymphoma

BCR-ABL1 positive Acute Lymphoblastic Leukemia


Botulinum Toxin Type A (Ipsen biopharm Limited)

United States
China
United Kingdom
Austria
Belgium
Bulgaria
Cyprus
Czechia
Germany
Denmark
Estonia
Spain
Finland
France
Greece
Croatia
Hungary
Ireland
Iceland
Italy
Lithuania
Luxembourg
Latvia
Malta
Netherlands
Norway
Poland
Portugal
Romania
Sweden
Slovenia
Slovakia


Recombinant coagulation factor VIII ( Sino Cell Technologies)

Recombinant human coagulation factor-VIII


Hepatitis C virus serine protease, NS3/NS4A

China
European Union
Canada
Switzerland
Iceland
Liechtenstein
Norway


United States
China
European Union
Japan
Canada
Iceland
Liechtenstein
Norway


Hepatitis C virus NS5B RNA-dependent RNA polymerase


Extramedullary Disease in Multiple Myeloma

Metastatic castration-resistant prostate cancer

United States
China
European Union
Japan
Australia
Iceland
Liechtenstein
Norway


United States
European Union
Japan
Australia
Iceland
Liechtenstein
Norway


Complicated skin and soft tissue infection

Complicated skin and skin structure infection

Non-complicated skin and skin structure infection


Insulin glargine biosimilar(Lunan Pharmaceutical Group Co., Ltd.)


Bacteremia due to Methicillin resistant Staphylococcus aureus

MRSA - Methicillin resistant Staphylococcus aureus infection

United States
China
European Union
Japan
Iceland
South Korea
Liechtenstein
Norway


Bosnia and Herzegovina
Ghana
Liberia
Paraguay


HER2 Positive Adenocarcinoma of Esophagus

HER2 Positive Gastroesophageal Adenocarcinoma

HER2 positive Gastroesophageal Junction Adenocarcinoma

Malignant neoplasm of gastro-oesophageal junction

Estrogen receptor positive breast cancer

Metastatic HER2 positive gastroesophageal junction cancer

Metastatic HER2-Negative Breast Carcinoma

Metastatic human epidermal growth factor 2 positive carcinoma of breast

United States
China
European Union
Canada
Australia
Switzerland
Indonesia
Iceland
South Korea
Liechtenstein
Norway
Thailand


Chemotherapy-induced nausea and vomiting

United States
China
European Union
Japan
Iceland
Liechtenstein
Norway


Hepatitis C virus serine protease, NS3/NS4A


Adult T-cell lymphoma/leukaemia refractory

Metastatic castration-resistant prostate cancer


Vitamin K epOxide reductase complex subunit 1


Major depressive disorder, moderate (MDD)

United States
China
European Union
Canada
Australia
Germany
Iceland
Liechtenstein
Norway


United States
European Union
Canada
Australia
Iceland
Liechtenstein
Norway


Neurotrophic tyrosine kinase receptor type 2

Neurotrophic tyrosine kinase receptor type 3

NTRK fusion-positive Central Nervous System Neoplasms


United States
European Union
Japan
Canada
Australia
Belgium
Cyprus
Czechia
France
Iceland
Liechtenstein
Lithuania
Luxembourg
Latvia
Norway
Portugal


Metastatic Non-Squamous Non-Small Cell Lung Carcinoma

Metastatic Carcinoma to the Uterine Cervix

Platinum-Resistant Epithelial Ovarian Carcinoma

Platinum-sensitive epithelial ovarian cancer

Platinum-Sensitive Fallopian Tube Carcinoma

Platinum-Sensitive Primary Peritoneal Carcinoma

Recurrent Platinum-Resistant Fallopian Tube Carcinoma

Recurrent Platinum-Resistant Primary Peritoneal Carcinoma

United States
European Union
Japan
Canada
Australia
Iceland
Liechtenstein
Norway


Concizumab (genetical recombination) (JAN)

United States
European Union
Japan
United Kingdom
Canada
Australia
Iceland
Liechtenstein
Norway


BRCA Mutation Castration-Resistant Prostate Cancer

Human epidermal growth factor 2 negative carcinoma of breast

Metastatic castration-resistant prostate cancer

Platinum-Resistant Primary Peritoneal Carcinoma

Locally Advanced Malignant Solid Neoplasm

Primary Peritoneal High-Grade Serous Adenocarcinoma

high grade serous adenocarcinoma of ovary

Recurrent Squamous Cell Carcinoma of the Head and Neck

Metastatic Microsatellite Stable Colorectal Carcinoma

Microsatellite instability-high colorectal cancer

Locally Advanced Head and Neck Squamous Cell Carcinoma

Recurrent High Grade Fallopian Tube Serous Adenocarcinoma

Metastatic human epidermal growth factor 2 positive carcinoma of breast

Hormone Receptor Positive Breast Adenocarcinoma

Hormone receptor positive HER2 negative breast cancer

Recurrent HER2-Negative Breast Carcinoma

Advanced Triple-Negative Breast Carcinoma

Germline BRCA-mutated, HER2-negative metastatic breast cancer

Metastatic Carcinoma to the Uterine Cervix

Metastatic Gastroesophageal Junction Adenocarcinoma

Metastatic Triple-Negative Breast Carcinoma

Recurrent Platinum-Resistant Ovarian Carcinoma

Recurrent Primary Peritoneal High Grade Serous Adenocarcinoma

Urothelial Carcinoma of the Urinary Bladder

United States
China
European Union
Japan
Canada
Australia
Switzerland
Iceland
South Korea
Liechtenstein
Norway


Transient receptor potential cation channel subfamily V member 1


Extravasation of Diagnostic and Therapeutic Materials

China
European Union
Japan
Australia
Iceland
Liechtenstein
Norway


United States
China
European Union
Iceland
Liechtenstein
Norway


Ibuprofen/Anhydrous Caffeine/DL-Methylephedrine Hydrochloride/Dextromethorphan Hydrobromide Hydrate/Guaifenesin


Retinal vein occlusion-related macular edema

European Union
Japan
Iceland
Liechtenstein
Norway


EGFR exon 19 Deletions Mutant Non-small Cell Lung Cancer

EGFR exon 21 Substitution Mutant Non-small Cell Lung Cancer

Locally Advanced Lung Non-Small Cell Carcinoma

EGFR positive non-small cell lung cancer

Locally Advanced Head and Neck Squamous Cell Carcinoma

Squamous cell carcinoma of head and neck metastatic

Squamous cell carcinoma of the oral cavity

United States
China
European Union
Japan
Canada
Iceland
South Korea
Liechtenstein
Norway


Adalimumab Biosimilar (Shilpa Biologicals)


Rituximab Biosimilar (Shandong New Time Pharmaceutical Co. Ltd.)

CD20 positive Diffuse Large B-Cell Lymphoma

Chronic lymphocytic leukaemia refractory


Complicated skin and soft tissue infection


Carperitide (genetical recombination) (JAN)


Anti-RANKL Monoclonal Antibody(Jinmante Biological)

Recombinant human anti-RANKL Antibody(Jinmante Biological)

Tumor necrosis factor ligand superfamily member 11


Proto-oncogene tyrosine-protein kinase ROS

Unresectable Lung Non-Small Cell Carcinoma

Locally Advanced Malignant Solid Neoplasm

Reactive oxygen species 1 positive non-small cell lung cancer


Sleep Initiation and Maintenance Disorders


Dapagliflozin propanediol monohydrate/Sitagliptin phosphate monohydrate


Interleukin-1 receptor antagonist anakinra

Deficiency of Interleukin-1 Receptor Antagonist

Neonatal-Onset Multisystem Inflammatory Disease

Systemic onset juvenile chronic arthritis

Polyarticular Juvenile Idiopathic Arthritis

United States
China
European Union
Australia
Iceland
Liechtenstein
Norway


Metastatic castration-resistant prostate cancer

Metastatic Gastroesophageal Junction Adenocarcinoma

Metastatic human epidermal growth factor 2 positive carcinoma of breast

Locally Advanced Head and Neck Squamous Cell Carcinoma

Locally Advanced Lung Non-Small Cell Carcinoma

Squamous Cell Carcinoma of Head and Neck

Recurrent Squamous Cell Carcinoma of the Head and Neck

Squamous cell carcinoma of head and neck metastatic

Non-Muscle Invasive Bladder Urothelial Carcinoma

Advanced Lung Non-Small Cell Squamous Carcinoma

Advanced Lung Non-Squamous Non-Small Cell Carcinoma

Advanced Triple-Negative Breast Carcinoma

HER2 positive Gastroesophageal Junction Adenocarcinoma

Human epidermal growth factor 2 negative carcinoma of breast

Locally Advanced Gastroesophageal Junction Adenocarcinoma

Locally Advanced Malignant Solid Neoplasm

Locally Advanced Unresectable Gastric Adenocarcinoma

Malignant neoplasm of gastro-oesophageal junction

Metastatic HER2-Negative Breast Carcinoma

Metastatic Non-Squamous Non-Small Cell Lung Carcinoma

Metastatic Urethral Urothelial Carcinoma

Platinum-Resistant Fallopian Tube Carcinoma

Primary Peritoneal Serous Adenocarcinoma

Recurrent HER2-Negative Breast Carcinoma

Renal Pelvis and Ureter Urothelial Carcinoma

Resectable Lung Non-Small Cell Carcinoma

Squamous cell carcinoma of the hypopharynx

Squamous cell carcinoma of the oral cavity

Transitional cell cancer of the renal pelvis and ureter recurrent

United States
China
European Union
Japan
Australia
Brazil
Iceland
Liechtenstein
Norway


Dihydrocodeine Tartrate/Chlorpheniramine Maleate/Methylephedrine Hydrochloride/Caffeine


Recombinant follicle-stimulating hormone (Ferring)

China
European Union
Japan
Canada
Australia
Iceland
Liechtenstein
Norway


Estrogen receptor positive breast cancer

Hormone receptor positive HER2 negative breast cancer

Human epidermal growth factor 2 negative carcinoma of breast

Metastatic human epidermal growth factor 2 positive carcinoma of breast

United States
China
Japan
Canada
Switzerland


Peroxisome proliferator-activated receptor delta

Metabolic Dysfunction Associated Steatohepatitis

United States
European Union
United Kingdom
Canada
Australia
Iceland
Liechtenstein
Norway


Endothelial PAS domain-containing protein 1

Locally Advanced Clear Cell Renal Cell Carcinoma

Recurrent Ovarian Clear Cell Adenocarcinoma

Locally Advanced Malignant Solid Neoplasm

United States
China
European Union
Japan
Canada
Australia
Iceland
South Korea
Liechtenstein
Norway


Locally Advanced Lung Non-Small Cell Carcinoma

ALK-positive anaplastic large cell lymphoma

Metastatic Non-Squamous Non-Small Cell Lung Carcinoma

RET fusion-positive Non-Small Cell Lung Cancer

RET Mutation-Positive Medullary Thyroid Cancer


Cytotoxic T-Lymphocyte-Associated Antigen 4

Microsatellite instability-high colorectal cancer

Mismatch repair-deficient Colonic Cancer

Locally Advanced Gastroesophageal Junction Adenocarcinoma

Locally Advanced Unresectable Gastric Adenocarcinoma

Metastatic Carcinoma to the Uterine Cervix

Metastatic Gastroesophageal Junction Adenocarcinoma

Locally Advanced Head and Neck Squamous Cell Carcinoma

Metastatic Pancreatic Ductal Adenocarcinoma

Locally Advanced Esophageal Squamous Cell Carcinoma

Metastatic Esophageal Squamous Cell Carcinoma

Unresectable Esophageal Squamous Cell Carcinoma

Locally Advanced Lung Non-Small Cell Carcinoma

Microsatellite Instability-high Solid Tumors


Compound 2a(Research Triangle Institute)

United States
China
Belgium
Brazil
Germany
Denmark
Finland
France
Ireland
Iceland
Italy
Luxembourg
Netherlands
Norway
Portugal
Sweden


Vascular endothelial growth factor receptor

Refractory Differentiated Thyroid Gland Carcinoma


Locally Advanced Lung Non-Squamous Non-Small Cell Carcinoma

Metastatic Non-Squamous Non-Small Cell Lung Carcinoma

Unresectable Pleural Malignant Mesothelioma

KRAS G12C mutant Non-small Cell Lung Cancer

EGFR positive non-small cell lung cancer

EGFR positive Non-squamous non-small cell lung cancer

KRAS G12C mutant non-squamous non-small cell lung cancer

Advanced Head and Neck Squamous Cell Carcinoma

Locally Advanced Malignant Solid Neoplasm

Locally Advanced Unresectable Gastric Adenocarcinoma

Recurrent Central Nervous System Lymphoma

Recurrent Platinum-Resistant Primary Peritoneal Carcinoma

Recurrent Squamous Cell Carcinoma of the Head and Neck

Resectable Lung Non-Small Cell Carcinoma

Squamous Cell Carcinoma of Head and Neck

Squamous cell carcinoma of head and neck metastatic

Unresectable Lung Non-Small Cell Carcinoma


4-aminobenzoic acid 2-diethylaminoethyl ester

Procaine Hydrochloride and Sodium Chloride

p-Aminobenzoic acid 2-diethylaminoethyl ester


United States
China
European Union
Hong Kong
Iceland
Liechtenstein
Norway
Singapore
Taiwan Province


5-hydroxytryptamine receptors, ionotropic (HTR3)


Ingredients:Japanese pepper, processed ginger, ginseng

TSUMURA Daikenchuto Extract Granules for Ethical Use


SARS-CoV-2 vaccine (COVID-19), Zydus-Cadila


ATPase secretory pathway Ca2+ transporting 1

glutamate ionotropic receptor AMPA type subunit 1


Insulin aspart biosimilar(Zhuhai United Laboratories Holding Ltd.)


Evinacumab (genetical recombination) (JAN)

United States
European Union
Japan
United Kingdom
Canada
Iceland
Liechtenstein
Norway


Calcium-activated potassium channel alpha/beta 1

MRSA - Methicillin resistant Staphylococcus aureus infection


Chemotherapy-induced nausea and vomiting

United States
China
European Union
Japan
Australia
Iceland
Liechtenstein
Norway


Attention Deficit Disorder With Hyperactivity

Attention Deficit and Disruptive Behavior Disorders

United States
China
Japan
Australia
South Korea


Recombinant cytokine gene derived protein(Genova)

Recombinant Cytokine Gene Derived Protein


Liver Disease Associated with Cystic Fibrosis

Metabolic Dysfunction Associated Steatohepatitis


Umeclidinium Bromide and Vilanterol Trifenatate

United States
China
European Union
Japan
Iceland
Liechtenstein
Norway


Myelin oligodendrocyte glycoprotein antibody-associated disease

Anti-myelin-associated glycoprotein associated polyneuropathy

Polyradiculoneuropathy, Chronic Inflammatory Demyelinating

United States
China
European Union
Japan
United Kingdom
Canada
Australia
Iceland
South Korea
Liechtenstein
Norway


Recurrent Mixed Phenotype Acute Leukemia

Refractory Adult Acute Lymphoblastic Leukemia

Refractory Mixed Phenotype Acute Leukemia

Accelerated phase Philadelphia chromosome positive chronic myeloid leukemia

Acute myeloid leukemia with multilineage dysplasia

Adult Acute Monoblastic and Monocytic Leukemia

Adult acute myeloid leukemia with del(5q)

Aggressive-Phase Chronic Myelocytic Leukemia

AIDS-Related Diffuse Large Cell Lymphoma

Anemia, Refractory, With Excess of Blasts

BCR-ABL Negative Atypical Chronic Myeloid Leukemia

Blast Phase Chronic Granulocytic Leukemia

Blastic Plasmacytoid Dendritic Cell Neoplasm

Childhood Nodular Sclerosis Classic Hodgkin Lymphoma

Chronic lymphocytic leukaemia refractory

Colorectal Cancer, Hereditary Nonpolyposis, Type 1

Human Papillomavirus-Related Cervical Carcinoma

Metastatic castration-resistant prostate cancer

pediatric lymphoblastic non-Hodgkin's lymphoma

Philadelphia chromosome positive chronic myelogenous leukemia

Philadelphia chromosome-positive chronic myeloid  leukemia in chronic phase

Primary Cutaneous Anaplastic Large Cell Lymphoma

Purine Nucleoside Phosphorylase Deficiency

Recurrent Adult Acute Lymphoblastic Leukemia

Recurrent Adult Grade III Lymphomatoid Granulomatosis

Recurrent Aggressive Non-Hodgkin Lymphoma

Recurrent Anaplastic Large Cell Lymphoma

Recurrent Childhood Acute Lymphoblastic Leukemia

Refractory Acute Undifferentiated Leukemia

Refractory cytopenia with multilineage dysplasia and ringed sideroblasts

Stage II Non-Contiguous Adult Diffuse Small Cleaved Cell Lymphoma

untreated pediatric acute nonlymphocytic leukemia

X-Linked Combined Immunodeficiency Diseases

Non-degrading molecular glue
Synthetic peptide
Cyclic Peptide

United States
China
European Union
Japan
Canada
Australia
Iceland
Liechtenstein
Norway


エルビテグラビル／コビシスタット／エムトリシタビン／ テノホビル アラフェナミドフマル酸塩

Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Alafenamide Fumarate


Interferon-alpha/beta receptor alpha chain

Lupus Vasculitis, Central Nervous System

Idiopathic Inflammatory Myopathy, Familial

United States
European Union
Japan
Canada
Australia
Iceland
Liechtenstein
Norway


Proto-oncogene tyrosine-protein kinase ROS

Metastatic Malignant Neoplasm to the Leptomeninges

United States
China
European Union
Japan
Australia
Iceland
South Korea
Liechtenstein
Norway


Autologous CD34+ cells encoding ARSA gene

United States
European Union
United Kingdom
Switzerland
Germany
France
Iceland
Italy
Liechtenstein
Norway


Calcitonin gene-related peptide type 1 receptor


Chemotherapy-induced nausea and vomiting

Metastatic human epidermal growth factor 2 positive carcinoma of breast


Protein kinase AMP-activated non-catalytic subunit beta 1


Recombinant Covid-19 Fusion Protein Vaccine(Livzon Mabpharm/Institute of Biophysics, Chinese Academy of Sciences)

Recombinant SARSCoV2 Fusion Protein Vaccine

Recombinant coronavirus fusion protein vaccine Livzon Mabpharm/Institute of Biophysics Chinese Academy of Sciences

V01 Livzon Mabpharm/Institute of Biophysics Chinese Academy of Sciences


Dementia due to Alzheimer's disease (disorder)

Squamous Cell Carcinoma of Head and Neck


Recombinant Human/Murine Chimeric Anti-CD20 Monoclonal Antibody

CD20 positive Diffuse Large B-Cell Lymphoma


Voltage-gated calcium channel alpha2/delta subunit 1

Voltage-gated calcium channel alpha2/delta subunit 2

Sleep Initiation and Maintenance Disorders

United States
China
European Union
Japan
Canada
Australia
Brazil
Iceland
South Korea
Liechtenstein
Norway


Recombinant adjuvanted COVID-19 Vaccine(Sanofi)

Adjuvanted recombinant proteinbased COVID19 vaccine Sanofi

SARS-CoV-2 Recombinant Protein Vaccine(Sanofi)

SARSCoV2 recombinant protein vaccine Sanofi


Estrogen receptor positive breast cancer


FGFR2 fusion or rearranged Cholangiocarcinoma

Urothelial Carcinoma of the Urinary Bladder

Metastatic Gastroesophageal Junction Adenocarcinoma

FGFR2 positive Gastrooesophageal Junction Cancer

Hormone receptor positive HER2 negative breast cancer

Renal Pelvis and Ureter Urothelial Carcinoma

Squamous Cell Carcinoma of Head and Neck

Squamous Cell Carcinoma of the Oropharynx


Piperacillin Sodium and Tazobactam Sodium (4:1)

Piperacillin Sodium and Tazobactam Sodium(4:1)

Complicated skin and soft tissue infection

Non-complicated skin and skin structure infection

Refractory cytopenia with multilineage dysplasia and ringed sideroblasts

United States
China
Japan
Australia
France


Retinal vein occlusion-related macular edema

United States
European Union
Canada
Iceland
Liechtenstein
Norway


Ecallantide (genetical recombination) (JAN)


Moderate chronic obstructive pulmonary disease


Humanised anti-IL-6 receptor monoclonal antibody

Satralizumab (genetical recombination) (JAN)

AQP4-IgG positive Neuromyelitis optica spectrum disorder

Myelin oligodendrocyte glycoprotein antibody-associated disease

Idiopathic pulmonary arterial hypertension

United States
China
European Union
Japan
Canada
Australia
Switzerland
Iceland
South Korea
Liechtenstein
Norway
Taiwan Province


Metastatic human epidermal growth factor 2 positive carcinoma of breast

Locally Advanced Malignant Solid Neoplasm

HER2 Positive Transitional Cell Carcinoma


United States
Canada
Australia
Switzerland
New Zealand


Anti-CD19 CAR T cell therapy (Autolus Therapeutics)

Precursor B-Cell Lymphoblastic Leukemia-Lymphoma

Recurrent B Acute Lymphoblastic Leukemia

Refractory B Acute Lymphoblastic Leukemia

CD19-positive B-cell acute lymphoblastic leukemia

Philadelphia positive acute lymphocytic leukaemia

Recurrent Childhood Acute Lymphoblastic Leukemia

United States
European Union
United Kingdom
Iceland
Liechtenstein
Norway


Recombinant Human Erythropoietin Injection (CHO Cell) (Kyowa Hakko Kirin

Anemia, Refractory, With Excess of Blasts


Rituximab biosimilar(Dr. Reddy's Laboratories)

Rituximab Biosimilar (Dr. Reddy's Laboratories Ltd.)

利妥昔单抗生物类似药（Dr. Reddy's Laboratories Ltd.）

CD20 positive Diffuse Large B-Cell Lymphoma

Chronic lymphocytic leukaemia refractory

European Union
India
Iceland
Liechtenstein
Norway


Aducanumab (genetical recombination) (JAN)


Darbepoetin alfa (genetical recombination) (JAN)

Novel erythropoiesis stimulating protein

Refractory cytopenia with multilineage dysplasia


Somapacitan (genetical recombination) (JAN)

United States
China
European Union
Japan
Canada
Australia
Iceland
South Korea
Liechtenstein
Norway


Voltage-gated calcium channel alpha2/delta subunit 1

Voltage-gated calcium channel alpha2/delta subunit 2


recombinant human Nerve Growth factor (rhNGF)

Low affinity neurotrophin receptor p75NTR

United States
China
European Union
Canada
Australia
Iceland
Liechtenstein
Norway


Inactivated SARS-CoV-2 Vaccine (Vero cell)(Chinese Academy of Medical Sciences)

COVID-19 Inactivated vaccine(Chinese Academy of Medical Sciences)


United States
China
European Union
Japan
Australia
Iceland
Liechtenstein
Norway


Immunoglobulin g1-kappa, anti-(homo sapiens b-lymphocyte antigen cd-19)chimeric monoclonal antibody conjugated to an average of two molecules of tesirine.gamma.1 heavy chain (1-449) (mus musculus vh (ighv1-69*02 (86%) (ighd)-ighj4*01)) (8.8.13) (1-120) -

Diffuse large B-cell lymphoma refractory

High grade B-cell lymphoma with MYC and BCL2 and/or BCL6 rearrangements

Secondary Central Nervous System Lymphoma

Precursor B-Cell Lymphoblastic Leukemia-Lymphoma

United States
China
European Union
Iceland
Liechtenstein
Norway


Sodium voltage-gated channel alpha subunits


Anti-HER2 monoclonal antibody( Zhejiang Hisun Pharmaceutical)

Pertuzumab Biosimilar (Zhejiang Hisun Pharmaceutical Co., Ltd.)

recombinant monoclonal antibody against human epidermal growth factor receptor injection


United States
China
Japan
Canada
Australia
Switzerland
South Korea


Reduced ejection fraction co-occurrent and due to chronic heart failure

Heart failure with normal ejection fraction

Heart failure with reduced ejection fraction

Hypertrophic Cardiomyopathy without Obstruction

United States
China
European Union
Japan
Canada
Australia
Switzerland
Iceland
Liechtenstein
Norway


Hormone receptor positive HER2 negative breast cancer


Metabolic Dysfunction Associated Steatohepatitis


Philadelphia chromosome positive chronic myelogenous leukemia


progressive familial intrahepatic cholestasis

Cholestasis, Progressive Familial Intrahepatic 1

United States
China
European Union
Japan
Canada
Hong Kong
Israel
Iceland
South Korea
Liechtenstein
Norway
Taiwan Province


Chronic rhinosinusitis without nasal polyps


Trastuzumab biosimilar(PT Kalbe Genexine)

Trastuzumab Biosimilar (PT Kalbe Genexine Biologics)

Hormone receptor negative HER2 positive breast cancer


Nivolumab (genetical recombination) (JAN)

Microsatellite instability-high Rectal Cancer

PD-L1 positive Non-Small Cell Lung Cancer

Malignant neoplasm of gastro-oesophageal junction

Resectable Lung Non-Small Cell Carcinoma

Urothelial Carcinoma of the Urinary Bladder

Squamous cell carcinoma of head and neck metastatic

HER2 negative Gastroesophageal Junction Adenocarcinoma

Locally Advanced Lung Non-Small Cell Carcinoma

Metastatic Esophageal Squamous Cell Carcinoma

Microsatellite instability-high colorectal cancer

Oesophageal squamous cell carcinoma recurrent

Recurrent Squamous Cell Carcinoma of the Head and Neck

Unresectable Esophageal Squamous Cell Carcinoma

Unresectable Pleural Malignant Mesothelioma

Squamous Cell Carcinoma of Head and Neck

Mismatch repair-deficient Colonic Cancer

Metastatic castration-resistant prostate cancer

Nodular Sclerosis Classical Hodgkin Lymphoma

Human Papillomavirus-Related larynx carcinoma

Advanced Lung Non-Small Cell Squamous Carcinoma

Metastatic Non-Squamous Non-Small Cell Lung Carcinoma

Hepatitis B Virus-Related Hepatocellular Carcinoma

Advanced Esophageal Squamous Cell Carcinoma

Recurrent Lung Non-Squamous Non-Small Cell Carcinoma

Metastatic Gastroesophageal Junction Adenocarcinoma

Advanced Gastroesophageal Junction Adenocarcinoma

Squamous Cell Carcinoma of the Oropharynx

Metastatic Clear Cell Renal Cell Carcinoma

Cutaneous Squamous Cell Carcinoma of the Head and Neck

Recurrent Transformed Chronic Lymphocytic Leukemia

Refractory Transformed Chronic Lymphocytic Leukemia

Recurrent Pharyngeal Squamous Cell Carcinoma

Relapsed Squamous Cell Carcinoma of the Larynx

Squamous cell carcinoma of the hypopharynx

Squamous cell carcinoma of the oral cavity recurrent

Cancer with a high tumour mutational burden

Fallopian Tube Clear Cell Adenocarcinoma

Recurrent Ovarian Clear Cell Adenocarcinoma

Recurrent Platinum-Resistant Fallopian Tube Carcinoma

Recurrent Platinum-Resistant Ovarian Carcinoma

Recurrent Platinum-Resistant Primary Peritoneal Carcinoma

Recurrent Primary Peritoneal Clear Cell Adenocarcinoma

Recurrent B Acute Lymphoblastic Leukemia

Chronic lymphocytic leukaemia refractory

Dyssegmental Dysplasia, Rolland-Desbuquois Type

Locally Advanced Esophageal Squamous Cell Carcinoma

Refractory Differentiated Thyroid Gland Carcinoma

thyroid gland poorly differentiated carcinoma

Diffuse large B-cell lymphoma refractory

Primary mediastinal large B-cell lymphoma recurrent

Human Papillomavirus-Related Head and Neck Neoplasms

HPV positive oropharyngeal squamous cell carcinoma

Locally Advanced Head and Neck Squamous Cell Carcinoma

Metastatic Urethral Urothelial Carcinoma

Muscle Invasive Bladder Urothelial Carcinoma

Small cell neuroendocrine carcinoma of bladder

Metastatic HER2-Negative Breast Carcinoma

Recurrent Central Nervous System Lymphoma

Refractory Central Nervous System Lymphoma

High grade B-cell lymphoma with MYC and BCL2 and/or BCL6 rearrangements

Proliferative verrucous oral leukoplakia

Microsatellite Instability-high Solid Tumors

Epstein-Barr virus associated lymphoproliferative disorder

Metastatic Triple-Negative Breast Carcinoma

Peripheral T-cell lymphoma unspecified recurrent

Refractory Systemic Anaplastic Large Cell Lymphoma

Primary Peritoneal High-Grade Serous Adenocarcinoma

Renal Pelvis and Ureter Urothelial Carcinoma

Squamous Cell Carcinoma of the Nasal Cavity

Well Differentiated Pancreatic Endocrine Tumor

Squamous cell carcinoma of the oral cavity

Undifferentiated carcinoma of nasopharynx

Metastatic Carcinoma to the Uterine Cervix

Metastatic Microsatellite Stable Colorectal Carcinoma

Microsatellite Stable Colorectal Carcinoma

Locally Advanced Unresectable Gastric Adenocarcinoma

Locally Advanced Malignant Solid Neoplasm

Advanced Pancreatic Ductal Adenocarcinoma

Locally Advanced Pancreatic Adenocarcinoma

Colorectal Cancer, Hereditary Nonpolyposis, Type 1

Advanced Thyroid Gland Medullary Carcinoma

Advanced Triple-Negative Breast Carcinoma

Metastatic Thyroid Gland Medullary Carcinoma

Recurrent Triple-Negative Breast Carcinoma

Unresectable Lung Non-Small Cell Carcinoma

Recurrent Transformed B-Cell Non-Hodgkin Lymphoma

Breast Carcinoma Metastatic in the Brain

Platinum-Resistant Fallopian Tube Carcinoma

Recurrent Mixed Phenotype Acute Leukemia

Refractory B Acute Lymphoblastic Leukemia

Refractory Mixed Phenotype Acute Leukemia

Sarcomatoid Transitional Cell Carcinoma of the Renal Pelvis

Acute Myeloid Leukemia with Myelodysplasia-Related Changes

Adult T-cell lymphoma/leukaemia refractory

Advanced Lung Non-Squamous Non-Small Cell Carcinoma

Blastic Plasmacytoid Dendritic Cell Neoplasm

Diffuse midline glioma, point mutation K27M in histone H3

EGFR positive Non-squamous non-small cell lung cancer

Estrogen receptor positive breast cancer

GRPR Positive/ER Positive/HER2 Negative Breast Cancer

HER2 Positive Gastroesophageal Adenocarcinoma

Hormone receptor positive HER2 negative breast cancer

Human epidermal growth factor 2 negative carcinoma of breast

KRAS-mutated low-grade serous ovarian cancer

Locally Advanced Clear Cell Renal Cell Carcinoma

Locally Advanced Hepatocellular Carcinoma

Metastatic malignant neoplasm to nasopharynx

Metastatic Malignant Neoplasm to the Leptomeninges

Metastatic Pancreatic Ductal Adenocarcinoma

Peripheral T-cell lymphoma unspecified refractory

Philadelphia chromosome positive chronic myelogenous leukemia

Philadelphia chromosome-positive acute lymphoblastic leukemia in relapse

Platinum-sensitive epithelial ovarian cancer

Platinum-Sensitive Lung Small Cell Carcinoma

Recurrent Adult Acute Lymphoblastic Leukemia

Recurrent Anaplastic Large Cell Lymphoma

Recurrent Childhood Acute Lymphoblastic Leukemia

Recurrent Gastroesophageal Junction Adenocarcinoma

Recurrent Primary Vitreoretinal Diffuse Large B-Cell Lymphoma

Refractory Diffuse Large B-Cell Lymphoma Activated B-Cell Type

Refractory Primary Vitreoretinal Diffuse Large B-Cell Lymphoma

Relapsed Nasopharyngeal Keratinizing Squamous Cell Carcinoma

Relapsed Undifferentiated Carcinoma of the Nasopharynx

T-cell/histiocyte rich large B-cell lymphoma

Treatment related acute myeloid leukaemia

Unresectable Gastrointestinal Stromal Tumor

United States
China
European Union
Japan
Australia
Iceland
South Korea
Liechtenstein
Norway
Taiwan Province


布洛芬/愈创甘油醚/盐酸伪麻黄碱/氢溴酸右美沙芬水合物/马来酸氯苯那敏/DL-盐酸甲基麻黄碱

Ibuprofen/Guaifenesin/Pseudoephedrine Hydrochloride/Dextromethorphan Hydrobromide Hydrate/Chlorpheniramine Maleate/DL-Methylephedrine Hydrochloride


Locally Advanced Lung Non-Small Cell Carcinoma

Metastatic Gastroesophageal Junction Adenocarcinoma

Metastatic Non-Squamous Non-Small Cell Lung Carcinoma

Squamous Cell Carcinoma of Head and Neck


Non-erosive gastro-esophageal reflux disease


Adalimumab biosimilar(Jiangsu Chia-tai Tianqing Pharmaceutical Co. Ltd.)

Adalimumab Biosimilar (Chia Tai Tianqing Pharmaceutical Group Co., Ltd.)


United States
China
Japan
United Kingdom
Australia


Clindamycin Hydrochloride and Sodium Chloride

Clindamycin Hydrochloride and Sodium Hydrochloride

Non-complicated skin and skin structure infection

Complicated skin and soft tissue infection


Metastatic HER2-Negative Breast Carcinoma

Metastatic human epidermal growth factor 2 positive carcinoma of breast


Proprotein convertase subtilisin kexin type 9


Erosive gastro-esophageal reflux disease


Tisotumab Vedotin (Genetical Recombination) (JAN)

Metastatic Carcinoma to the Uterine Cervix

Recurrent Squamous Cell Carcinoma of the Head and Neck

Squamous cell carcinoma of head and neck metastatic

Locally Advanced Malignant Solid Neoplasm

Platinum-Resistant Primary Peritoneal Carcinoma

United States
European Union
Japan
United Kingdom
Hong Kong
Iceland
Liechtenstein
Macao
Norway


Transforming growth factor beta receptor 2

PD-L1 positive Gastroesophageal junction adenocarcinoma

Malignant neoplasm of gastro-oesophageal junction

Metastatic Gastroesophageal Junction Adenocarcinoma

EGFR positive Non-squamous non-small cell lung cancer

Metastatic castration-resistant prostate cancer

Locally Advanced Lung Non-Small Cell Carcinoma

Advanced Head and Neck Squamous Cell Carcinoma

EGFR positive non-small cell lung cancer

Metastatic Non-Squamous Non-Small Cell Lung Carcinoma


Diffuse large B-cell lymphoma refractory

Primary mediastinal large B-cell lymphoma recurrent

European Union
Iceland
Liechtenstein
Norway


Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis


Ibuprofen/Pseudoephedrine Hydrochloride/Chlorpheniramine Maleate/Bromhexine Hydrochloride


anti-Csf1R monoclonal antibody SNDX-6352

BCR-ABL Negative Atypical Chronic Myeloid Leukemia


Advanced Triple-Negative Breast Carcinoma

Metastatic Pancreatic Ductal Adenocarcinoma

Precursor T-Cell Lymphoblastic Leukemia-Lymphoma


Metastatic HER2 positive gastroesophageal junction cancer

Squamous Cell Carcinoma of Head and Neck

Metastatic Triple-Negative Breast Carcinoma

Locally Advanced Malignant Solid Neoplasm

Metastatic Clear Cell Renal Cell Carcinoma

Muscle Invasive Bladder Urothelial Carcinoma

Squamous cell carcinoma of head and neck metastatic

Unresectable Pleural Malignant Mesothelioma

Urothelial Carcinoma of the Urinary Bladder

United States
European Union
Japan
Canada
Iceland
Liechtenstein
Norway


Human immunodeficiency virus type 1 protease


HER2 Positive Gastrointestinal Neoplasms

Malignant neoplasm of gastro-oesophageal junction

Advanced Pancreatic Ductal Adenocarcinoma

CD20 positive Diffuse Large B-Cell Lymphoma

CD30-positive diffuse large B-cell lymphoma

Chronic lymphocytic leukaemia refractory

HER2 positive Gastroesophageal Junction Adenocarcinoma

HER2 positive Gastrooesophageal junction cancer

Locally Advanced Gastroesophageal Junction Adenocarcinoma

Locally Advanced Head and Neck Squamous Cell Carcinoma

Locally Advanced Hepatocellular Carcinoma

Locally Advanced Pancreatic Adenocarcinoma

Metastatic Carcinoma to the Uterine Cervix

Metastatic Gastroesophageal Junction Adenocarcinoma

Metastatic human epidermal growth factor 2 positive carcinoma of breast

Metastatic Triple-Negative Breast Carcinoma

Platinum-Resistant Fallopian Tube Carcinoma

Recurrent Gastroesophageal Junction Adenocarcinoma

Squamous cell carcinoma of head and neck metastatic

Unresectable Lung Non-Small Cell Carcinoma

Urothelial Carcinoma of the Urinary Bladder


Chronic idiopathic thrombocytopenic purpura


Chemotherapy-induced nausea and vomiting

Hydrocephalus, Endocardial Fibroelastosis, and Cataracts


BRAF mutation positive hairy cell leukemia

BRAF V600E mutation-positive low grade glioma

BRAF V600E Mutation-Positive Anaplastic Thyroid Cancer

BRAF Mutation Non-small Cell Lung Cancer

BRAF V600E mutant Non-small Cell Lung Cancer

BRAF V600E Mutation-Positive Solid Tumors

BRAF V600 Mutation-Positive Non-small Cell Lung Cancer

BRAF V600K Mutation-Positive Solid Tumors

Desmoplastic Cerebral Astrocytoma of Infancy

Glioblastoma Harboring BRAF V600 Mutation

Locally Advanced Malignant Solid Neoplasm

Refractory Differentiated Thyroid Gland Carcinoma

United States
China
European Union
Japan
Australia
Iceland
South Korea
Liechtenstein
Norway


United States
European Union
Canada
Australia
Iceland
Liechtenstein
Norway


Anti-plasma kallikrein monoclonal antibody

Lanadelumab (genetical recombination) (JAN)

United States
China
European Union
Japan
Canada
Australia
Switzerland
Iceland
South Korea
Liechtenstein
Norway


Immunoglobulin G1, anti-(human beta-amyloid protofibril) (human-mus musculus monoclonal BAN2401 heavy chain), disulfide with human-mus musculus monoclonal BAN2401 light chain, dimer

Dementia due to Alzheimer's disease (disorder)

United States
China
European Union
Japan
United Kingdom
Canada
Australia
United Arab Emirates
Hong Kong
Israel
Iceland
South Korea
Liechtenstein
Mexico
Norway